Professional Documents
Culture Documents
36136 3
GOVERNMENT NOTICE
GOEWERMENTSKENNISGEWING
DEPARTMENT OF HEALTH
DEPARTEMENT VAN GESONDHEID
No. 74 6 February 2013
1. The applicant shall ensure that the medicine is manufactured and controlled in
terms of the current Good Manufacturing Practices as determined by Council
2. The manufacture of this medicine is subject to regular investigation and
inspections by the inspectors appointed in terms of Section 26 of the Act, to
assess compliance with current Good Manufacturing Practices.
3. The information in the package insert shall be updated on a regular basis to
conform to the package insert recently approved by Council.
4. The applicant must comply with all the legal requirements of the Medicines and
Related Substances Act, 1965 (Act 101 of 1965).
5. The registration of this medicine shall be subject to review at intervals as
determined by Council regarding its quality, safety and efficacy, and the
registration of this medicine may be varied subject to issues Council may deem
fit.
6. The first two production batches must be fully validated in terms of the detailed
process validation protocol submitted at the time of application for registration,
and the validation report must be submitted within a month after completion of
the validation.
7. The product may be advertised to the professions only.
8. The provisional shelf-life allocated must be confirmed with stability data over the
full shelf-life period on the first two production batches (well-known API) or first
three production batches (NCE) in accordance with the Stability Guideline.
Stability testing submitted on any pilot batches must also be completed and
reported, on. The stability report must be submitted within six months after
completion of the stability trial. However, Council has to be informed immediately
if any parameter shows a significant change or out-of-specification result during
the stability trial.
9. A post-registration inspection must be conducted on the first production batch
manufactured by each local manufacturer.
10. A post-registration inspection must be conducted on the first production batch of
the imported product.
11. Marketing of the product may only commence following a satisfactory post-
registration inspection report.
12. One sample of every batch, together with four copies of the protocol for testing of
the bulk lot and filling lot, and six copies of the certificate of release issued by a
competent authority in the country in which the product was manufactured, must
be submitted to the Council for lot release purposes.
13. The expiry date allocated shall be modified by adding a statement that the virus
strains are currently recommended for South African usage in the specific year.
14. The strains of the master seed viruses must be approved by the Department of
Health for each year.
MRF 15 MRF15 F 15
Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012
No. 36136
5
6
No. 36136
MRF 15 MRF15 F 15
Name of medicine: EXFORGE 5/320 mg Name of medicine: EXFORGE 10/320 mg Name of medicine: ENOXAPARIN SODIUM 20 WINTHROP
Dosage form: TABLET Dosage form: TABLET Dosage form: INJECTION
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH 0,2 ml SOLUTION CONTAINS:
Amlodipine besylate equivalent to Amlodipine besylate equivalent to ENOXAPARIN SODIUM 20,0 mg
Amlodipine 5,0 mg Amlodipine 10,0 mg
Valsartan 320,0 mg Valsartan 320,0 mg
Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7
registration: registration:
SANOFI-AVENTIS SOUTH AFRICA (PTY)
Applicant: NOVARTIS SA (PTY) LTD Applicant: NOVARTIS SA (PTY) LTD Applicant: LTD
Manufacturer: NOVARTIS PHARMA STEIN AG, Manufacturer: NOVARTIS PHARMA STEIN AG, Manufacturer: AVENTIS INTERNATIONAL, MAISONS-
STEIN, SWITZERLAND STEIN, SWITZERLAND ALFORT-CEDEX, FRANCE
AVENTIS PHARMA LE TRAIT, LE TRAIT,
FRANCE
Packer: NOVARTIS PHARMA STEIN AG, Packer: NOVARTIS PHARMA STEIN AG, Packer: AVENTIS INTERNATIONAL, MAISONS-
STEIN, SWITZERLAND STEIN, SWITZERLAND ALFORT-CEDEX, FRANCE
ALLPACK AG, REINACH, ALLPACK AG, REINACH, AVENTIS PHARMA LE TRAIT, LE TRAIT,
SWITZERLAND SWITZERLAND FRANCE
SANDOZ SA (PTY) LTD, SPARTAN, SANDOZ SA (PTY) LTD, SPARTAN, WINTHROP PHARMACEUTICALS,
KEMPTON PARK, RSA KEMPTON PARK, RSA WALTLOO, PRETORIA, RSA
KONAPHARMA AG, PRATTELN, KONAPHARMA AG, PRATTELN,
SWITZERLAND SWITZERLAND
IVERS-LEE AG, BURGDORF, IVERS-LEE AG, BURGDORF,
SWITZERLAND SWITZERLAND
Laboratory: F.PRC: NOVARTIS PHARMA STEIN AG, Laboratory: FPRC: NOVARTIS PHARMA STEIN AG, Laboratory: FPRC AVENTIS INTERNATIONAL, MAISONS-
STEIN, SWITZERLAND STEIN, SWITZERLAND ALFORT-CEDEX, FRANCE
NOVARTIS PHARMANALYTICA SA, NOVARTIS PHARMANALYTICA SA, AVENTIS PHARMA LE TRAIT, LE TRAIT,
LOCARNO, SWITZERLAND LOCARNO, SWITZERLAND FRANCE
SANDOZ SA (PTY) LTD, SPARTAN, SANDOZ SA (PTY) LTD, SPARTAN,
KEMPTON PARK, RSA KEMPTON PARK, RSA
M&L LABORATORY SERCICES M&L LABORATORY SERCICES
STAATSKOERANT, 6 FEBRUARIE 2013
number:
Name of medicine: ENOXAPARIN SODIUM 40 WINTHROP Name of medicine: ENOXAPARIN SODIUM 60 Name of medicine: ENOXAPARIN SODIUM 80
WINTHROP WINTHROP
Dosage form: INJECTION Dosage form: INJECTION Dosage form: INJECTION
Active ingredients: EACH 0,4 ml SOLUTION CONTAINS: Active ingredients: EACH 0,6 ml SOLUTION Active ingredients: EACH 0,8 ml SOLUTION
ENOXAPARIN SODIUM 40,0 mg CONTAINS: CONTAINS:
ENOXAPARIN SODIUM 60,0 mg ENOXAPARIN SODIUM 80,0 mg
Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7
registration: registration:
SANOFI-AVENTIS SOUTH AFRICA SANOFI-AVENTIS SOUTH AFRICA SANOFI-AVENTIS SOUTH
Applicant: (PTY) LTD Applicant: (PTY) LTD Applicant: AFRICA (PTY) LTD
Manufacturer: AVENTIS INTERNATIONAL, MAISONS- Manufacturer: AVENTIS INTERNATIONAL, Manufacturer: AVENTIS INTERNATIONAL,
ALFORT-CEDEX, FRANCE MAISONS-ALFORT-CEDEX, MAISONS-ALFORT-CEDEX,
AVENTIS PHARMA LE TRAIT, LE FRANCE FRANCE
TRAIT, FRANCE AVENTIS PHARMA LE TRAIT, LE AVENTIS PHARMA LE TRAIT, LE
TRAIT, FRANCE TRAIT, FRANCE
Packer: AVENTIS INTERNATIONAL, MAISONS- Packer: AVENTIS INTERNATIONAL, Packer: AVENTIS INTERNATIONAL,
ALFORT-CEDEX, FRANCE MAISONS-ALFORT-CEDEX, MAISONS-ALFORT-CEDEX,
AVENTIS PHARMA LE TRAIT, LE FRANCE FRANCE
TRAIT, FRANCE AVENTIS PHARMA LE TRAIT, LE AVENTIS PHARMA LE TRAIT, LE
WINTHROP PHARMACEUTICALS, TRAIT, FRANCE TRAIT, FRANCE
WALTLOO, PRETORIA, RSA WINTHROP PHARMACEUTICALS, WINTHROP
WALTLOO, PRETORIA, RSA PHARMACEUTICALS, WALTLOO,
PRETORIA, RSA
Laboratory: FPRC: AVENTIS INTERNATIONAL, MAISONS- Laboratory: FPRC: AVENTIS INTERNATIONAL, Laboratory: FPRC: AVENTIS INTERNATIONAL,
ALFORT-CEDEX, FRANCE MAISONS-ALFORT-CEDEX, MAISONS-ALFORT-CEDEX,
AVENTIS PHARMA LE TRAIT, LE FRANCE FRANCE
TRAIT, FRANCE AVENTIS PHARMA LE TRAIT, LE AVENTIS PHARMA LE TRAIT, LE
TRAIT, FRANCE TRAIT, FRANCE
FPRC/FPRR: WINTHROP PHARMACEUTICALS FPRC/FPRR: WINTHROP PHARMACEUTICALS FPRC/FPRR WINTHROP PHARMACEUTICALS
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
FPRR: SANOFI-AVENTIS S.A., MIDRAND, RSA FPRR: SANOFI-AVENTIS S.A., MIDRAND, FPRR: SANOFI-AVENTIS S.A.,
RSA MIDRAND, RSA
Shelf-life: 24 months Shelf-life: 24 months Shelf-life: 24 months
Date of 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012
registration:
300399—B
MRF 15 MRF15 F15
Name of medicine: ENOXAPARIN SODIUM 100 WINTHROP Name of medicine: ENOXAPARIN SODIUM 300 WINTHROP Name of medicine: CLAMGEN IV 0,6
Active ingredients: EACH 1,0 ml SOLUTION CONTAINS: Active ingredients: EACH 3,0 ml SOLUTION CONTAINS: Active ingredients: EACH VIAL CONTAINS:
ENOXAPARIN SODIUM 100,0 mg ENOXAPARIN SODIUM 300,0 mg AMOXICILLIN SODIUM EQUIVALENT TO
AMOXICILLIN 500,0 mg
POTASSIUM CLAVULANATE EQUIVALENT TO
CLAVULANIC ACID 100,0 mg
Conditions of registration' 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7
registration:
SANOFI-AVENTIS SOUTH AFRICA SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD
Applicant: (PTY) LTD Applicant: Applicant: XIXIA PHARMACEUTICALS (PTY) LTD
Manufacturer: AVENTIS INTERNATIONAL, MAISONS- Manufacturer: AVENTIS INTERNATIONAL, MAISONS- Manufacturer: GLAXO SMITHKLINE PHARMACEUTICALS,
ALFORT-CEDEX, FRANCE ALFORT-CEDEX, FRANCE WORTHING, SUSSEX, UK
AVENTIS PHARMA LE TRAIT, LE AVENTIS PHARMA LE TRAIT, LE TRAIT,
TRAIT, FRANCE FRANCE
Packer: AVENTIS INTERNATIONAL, MAISONS- Packer: AVENTIS INTERNATIONAL, MAISONS- Packer GLAXO SMITHKLINE PHARMACEUTICALS,
ALFORT-CEDEX, FRANCE ALFORT-CEDEX, FRANCE WORTHING, SUSSEX, UK
AVENTIS PHARMA LE TRAIT, LE AVENTIS PHARMA LE TRAIT, LE TRAIT,
TRAIT, FRANCE FRANCE
WINTHROP PHARMACEUTICALS, WINTHROP PHARMACEUTICALS, WALTLOO,
WALTLOO, PRETORIA, RSA PRETORIA, RSA
Laboratory: FPRC : AVENTIS INTERNATIONAL, MAISONS- Laboratory: FPRC: AVENTIS INTERNATIONAL, MAISONS- Laboratory: FPRC GLAXO SMITHKLINE PHARMACEUTICALS,
ALFORT-CEDEX, FRANCE ALFORT-CEDEX, FRANCE WORTHING, SUSSEX, UK
AVENTIS PHARMA LE TRAIT, LE AVENTIS PHARMA LE TRAIT, LE TRAIT, GENERICS (UK) LTD, STATION CLOSE,
TRAIT, FRANCE FRANCE HERTFORDSHIRE, UK
GERARD LABORATORIES, DUBLIN, IRELAND
SABS COMMERCIAL (PTY) LTD
PHARMACEUTICAL CHEMISTRY DEPARTMENT;
GROENKLOOF, PRETORIA, RSA
MERCK PHARMACEUTICAL MANUFACTURING,
WADEVILLE, GERMISTON
STAATSKOERANT, 6 FEBRUARIE 2013
Dosage form: INJECTION Dosage form: POWDER FOR INJECTION Dosage form: POWDER FOR INJECTION
Active ingredients: EACH VIAL CONTAINS: Active ingredients: EACH VIAL CONTAINS: EACH VIAL CONTAINS:
Active ingredients:
AMOXICILLIN SODIUM EQUIVALENT PIPERACILLIN SODIUM EQUIVALENT TO PIPERACILLIN SODIUM EQUIVALENT
TO AMOXICILLIN 1 000,0 mg PIPERACILLIN 2,0 g TO
POTASSIUM CLAVULANATE TAZOBACTAM SODIUM EQUIVALENT TO PIPERACILLIN 3,0 g
EQUIVALENT TO TAZOBACTAM 0,250 g TAZOBACTAM SODIUM EQUIVALENT
CLAVULANIC ACID 200,0 mg TO
TAZOBACTAM 0,375 g
Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8
registration: registration:
Applicant: XIXIA PHARMACEUTICALS (PTY) LTD Applicant LITHA PHARMA (PTY) LTD LITHA PHARMA (PTY) LTD
Applicant:
Manufacturer: GLAXO SMITHKLINE Manufacturer: MITIM S.r.L, BRESCIA, ITALY Manufacturer: MITIM S.r.L, BRESCIA, ITALY
PHARMACEUTICALS, WORTHING,
SUSSEX, UK
Packer: GLAXO SMITHKLINE Packer: MITIM S.r.L, BRESCIA, ITALY Packer: MITIM S.r.L, BRESCIA, ITALY
PHARMACEUTICALS, WORTHING,
SUSSEX, UK
Laboratory: FPRC: GLAXO SMITHKLINE Laboratory: FPRC: MITIM S.r.L, BRESCIA, ITALY MITIM S.r.L, BRESCIA, ITALY
Laboratory::FPRC
PHARMACEUTICALS, WORTHING, CONSULTING CHEMICAL LABORATORIES (PTY) CONSULTING CHEMICAL
SUSSEX, UK LTD, ATLASVILLE, BOKSBURG, RSA LABORATORIES (PTY) LTD,
GENERICS (UK) LTD, STATION SEDEKAGRICHEM, SILVERTONDALE, PRETORIA, ATLASVILLE, BOKSBURG, RSA
CLOSE, HERTFORDSHIRE, UK RSA SEDEKAGRICHEM, SILVERTONDALE,
GERARD LABORATORIES, DUBLIN, PRETORIA, RSA
IRELAND
SABS COMMERCIAL (PTY) LTD
PHARMACEUTICAL CHEMISTRY
DEPARTMENT; GROENKLOOF,
PRETORIA, RSA
MERCK PHARMACEUTICAL
MANUFACTURING, WADEVILLE,
GERMISTON
RESEARCH INSTITUTE FOR
INDUSTRIAL PHARMACY, NORTH-
WEST UNIVERSITY,
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
POTCHEFSTROOM, RSA
FPRR: XIXIA PHARMACEUTICALS, FPRR: LITHA PHARMA (PTY) LTD, MIDRAND, RSA FPRR LITHA PHARMA (PTY) LTD, MIDRAND,
MODDERFONTEIN, RSA
JOHANNESBURG, RSA
CONSULTING CHEMICAL
LABORATORIES,
ATLASVILLE, BOKSBURG,
RSA
KHULULEKANI
LABORATORY SERVICES,
COVENTRY PARK,
MIDRAND, RSA
FPRR: LITHA PHARMA (PTY) LTD, FPRR: FPRR:
NOVARTIS SA (PTY) LTD, SCHERING-PLOUGH,
MIDRAND, RSA SPARTAN, KEMPTON PARK, RSA WOODMEAD, SANDTON,
RSA
Shelf-life: 24 months (Provisional) Shelf-life: 24 months Shelf-life: 24 months (Provisional)
Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012 Date of 26 OCTOBER 2012
No. 36136
registration:
11
12
MRF 15 MRF15 F 15
No. 36136
Active ingredients: EACH CAPSULE CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
TEMOZOLOMIDE 180,0 mg Pramipexole dihydrochloride Pramipexole dihydrochloride monohydrate
monohydrate 0,25 mg 0,125 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of 1, 2, 3, 4, 5, 6, 7, 8
registration:
Applicant: SCHERING-PLOUGH (PTY) LTD Applicant: GULF DRUG COMPANY (PTY) LTD Applicant: GULF DRUG COMPANY (PTY) LTD
Manufacturer: ORION CORPORATION, TURKU, Manufacturer ALEMBIC LIMITED (FORMULATION Manufacturer: ALEMBIC LIMITED (FORMULATION DIVISION),
FINLAND DIVISION), TAL-HALOL, DISTRICT TAL-HALOL, DISTRICT PANCHMAHALS,
PANCHMAHALS, GUJARAT, INDIA GUJARAT, INDIA
Packer: ORION CORPORATION, TURKU, Packer: ALEMBIC LIMITED (FORMULATION Packer: ALEMBIC LIMITED (FORMULATION DIVISION),
FINLAND DIVISION), TAL-HALOL, DISTRICT TAL-HALOL, DISTRICT PANCHMAHALS,
SCHERING-PLOUGH LABO NM., PANCHMAHALS, GUJARAT, INDIA GUJARAT, INDIA
HEIST-OP-DEN-BERG, BELGIUM
Laboratory: FPRC: ORION CORPORATION, TURKU, Laboratory: FPRC: ALEMBIC LIMITED (FORMULATION Laboratory: FPRC: ALEMBIC LIMITED (FORMULATION DIVISION),
FINLAND DIVISION), TAL-HALOL, DISTRICT TAL-HALOL, DISTRICT PANCHMAHALS,
SCHERING-PLOUGH LABO N.V., PANCHMAHALS, GUJARAT, INDIA GUJARAT, INDIA
HEIST-OP-DEN-BERG, BELGIUM SABS COMMERCIAL (PTY) LTD SABS COMMERCIAL (PTY) LTD
SGS LAB SIMON SA, WAVRE, PHARMACEUTICAL CHEMISTRY PHARMACEUTICAL CHEMISTRY DEPARTMENT
BELGIUM DEPARTMENT GROENKLOOF, GROENKLOOF, PRETORIA, RSA
CONSULTING CHEMICAL PRETORIA, RSA M&L LABORATORY SERCICES (PTY) LTD,
LABORATORIES, ATLASVILLE, M&L LABORATORY SERCICES (PTY) LIMBRO BUSINESS PARK, SANDTON, RSA
BOKSBURG, RSA LTD, LIMBRO BUSINESS PARK, CONSULTING CHEMICAL LABORATORIES (PTY)
KHULULEKANI LABORATORY SANDTON, RSA LTD, ATLASVILLE, BOKSBURG, RSA
SERVICES, COVENTRY PARK, CONSULTING CHEMICAL INSTITUTE FOR PHARMACEUTICAL SERVICES,
MIDRAND, RSA LABORATORIES (PTY) LTD, SILVERTONDALE, PRETORIA, RSA
ATLASVILLE, BOKSBURG, RSA CONSULTING MICROBIOLOGICAL PHARMA-Q
INSTITUTE FOR PHARMACEUTICAL (PTY) LTD, INDUSTRIA WEST,
SERVICES, SILVERTONDALE, JOHANNESBURG, RSA
PRETORIA, RSA
CONSULTING MICROBIOLOGICAL
PHARMA -Q (PTY) LTD, INDUSTRIA
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
Name of medicine: DRL LEVOFLOXACIN 250 Name of medicine: DRL LEVOFLOXACIN 500 Name of medicine: GENEXOL 300 mg
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH CONTAINS: Active ingredients: EACH VIAL CONTAINS:
Levofloxacin 250,0 mg Levofloxacin 500,0 mg PACLITAXEL 300,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8
Applicant: DR REDDY'S LABORATORIES (PTY) LTD Applicant: DR REDDY'S LABORATORIES (PTY) LTD Applicant: PHARMACORP cc
Manufacturer: DR REDDY'S LABORATORIES LIMITED Manufacturer: DR REDDY'S LABORATORIES LIMITED Manufacturer: INTAS PHARMACEUTICALS LTD, MATODA,
(GENERICS), QUTHUBULLAPUR (GENERICS), QUTHUBULLAPUR MANDAL, TALUKA-SANAND, AHMEDABAD, INDIA
MANDAL, RANGA REDDY DISTRICT, RANGA REDDY DISTRICT, ANDHRA
ANDHRA PRADESH, INDIA PRADESH, INDIA
DR REDDY'S LABORATORIES LIMITED DR REDDY'S LABORATORIES LIMITED
(FTO/FM-II), QUTHUBULLAPUR (FTO/FM-II), QUTHUBULLAPUR MANDAL,
MANDAL, RANGA REDDY DISTRICT, RANGA REDDY DISTRICT, ANDHRA
ANDHRA PRADESH, INDIA PRADESH, INDIA
Packer: DR REDDY'S LABORATORIES LIMITED Packer: DR REDDY'S LABORATORIES LIMITED Packer: INTAS PHARMACEUTICALS LTD, MATODA,
(GENERICS), QUTHUBULLAPUR (GENERICS), QUTHUBULLAPUR MANDAL, TALUKA-SANAND, AHMEDABAD, INDIA
MANDAL, RANGA REDDY DISTRICT, RANGA REDDY DISTRICT, ANDHRA
ANDHRA PRADESH, INDIA PRADESH, INDIA
DR REDDY'S LABORATORIES LIMITED DR REDDY'S LABORATORIES LIMITED
(FTO/FM-II), QUTHUBULLAPUR (FTO/FM-II), QUTHUBULLAPUR MANDAL,
MANDAL, RANGA REDDY DISTRICT, RANGA REDDY DISTRICT, ANDHRA
ANDHRA PRADESH, INDIA PRADESH, INDIA
DRA PHARMACEUTICALS, IRENE, DRA PHARMACEUTICALS, IRENE,
CENTURION, RSA CENTURION, RSA
Laboratory: FPRC: DR REDDY'S LABORATORIES LIMITED Laboratory: FPRC: DR REDDY'S LABORATORIES LIMITED Laboratory: FPRC: INTAS PHARMACEUTICALS LTD, MATODA,
(GENERICS), QUTHUBULLAPUR (GENERICS), QUTHUBULLAPUR MANDAL, TALUKA-SANAND, AHMEDABAD, INDIA
MANDAL, RANGA REDDY DISTRICT, RANGA REDDY DISTRICT, ANDHRA COLUMBIA PHARMACEUTICALS, BARDENE,
ANDHRA PRADESH, INDIA PRADESH, INDIA BOKSBURG, RSA
DR REDDY'S LABORATORIES LIMITED DR REDDY'S LABORATORIES LIMITED
(FTO/FM-II), QUTHUBULLAPUR (FTO/FM-II), QUTHUBULLAPUR MANDAL,
MANDAL, RANGA REDDY DISTRICT, RANGA REDDY DISTRICT, ANDHRA
ANDHRA PRADESH, INDIA PRADESH, INDIA
INSTITUTE FOR PHARMACEUTICAL INSTITUTE FOR PHARMACEUTICAL
SERVICES, SILVERTONDALE, SERVICES, SILVERTONDALE, PRETORIA,
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
Quetiapine hemifumarate Quetiapine hemifumarate FLUNARIZINE
equivalent to Quetiapine equivalent to Quetiapine HYDROCHLORIDE
25,0 mg 25,0 mg EQUIVALENT TO
FLUNARIZINE 5,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: Conditions of
1, 2, 3, 4, 5, 6, 7,8 1, 2, 3, 4, 5, 6, 7
registration:
Applicant: SANDOZ. SA (PTY) LTD Applicant: SANDOZ SA (PTY) LTD Applicant: JANSSEN PHARMACEUTICA
(PTY) LTD
Manufacturer: SANDOZ ILAC SANAYI VE Manufacturer: SANDOZ ILAC SANAYI VE Manufacturer:
JANSSEN-CILAG S.P.A, LATINA,
TICARET A.S, GEBZE- TICARET A.S, GEBZE- ITALY
KOCAELI, TURKEY KOCAELI, TURKEY
Packer: SANDOZ ILAC SANAYI VE Packer: SANDOZ ILAC SANAYI VE Packer:
JANSSEN-CILAG S.P.A, LATINA,
TICARET A.S, GEBZE- TICARET A.S, GEBZE- ITALY
KOCAELI, TURKEY KOCAELI, TURKEY SPECPHARM HOLDINGS (PTY)
TECHNIKON TECHNIKON LTD, HALFWAY HOUSE,
LABORATORIES (PTY) LTD, LABORATORIES (PTY) LTD, MIDRAND, RSA
ROBERTVILLE, FLORIDA, ROBERTVILLE, FLORIDA,
RSA RSA
SANDOZ SA, SPARTAN, SANDOZ SA, SPARTAN,
KEMPTON PARK, RSA KEMPTON PARK, RSA
Laboratory: FPRC: SANDOZ ILAC SANAYI VE Laboratory: FPRC: SANDOZ ILAC SANAYI VE Laboratory: FPRC: JANSSEN-CILAG S.P.A, LATINA,
TICARET A.S, GEBZE- TICARET A.S, GEBZE- ITALY
KOCAELI, TURKEY KOCAELI, TURKEY SPECPHARM HOLDINGS (PTY)
CONSULTING CHEMICAL CONSULTING CHEMICAL LTD, HALFWAY HOUSE,
LABORATORIES (PTY) LTD, LABORATORIES (PTY) LTD, MIDRAND, RSA
ATLASVILLE, BOKSBURG, ATLASVILLE, BOKSBURG,
RSA RSA
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
Dosage form: TABLET Dosage form: TABLET Dosage form: POWDER FOR INJECTION
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH VIAL CONTAINS:
ROPINIROLE HCI 2,0 mg ROPINIROLE HCI 5,0 mg TEMOZOLOMIDE 100,0 mg
Conditions of registration: Conditions of registration: Conditions of registration:
1, 2, 3, 4, 5, 6, 7 1, 2, 3, 4, 5, 6, 7 1, 2, 3, 4, 5, 6, 7
Applicant: ACCORD HEALTHCARE (PTY) Applicant: ACCORD HEALTHCARE (PTY) Applicant: SCHERING-PLOUGH (PTY)
LTD LTD LTD
Manufacturer: INTAS PHARMACEUTICALS Manufacturer. Manufacturer.
INTAS PHARMACEUTICALS BAXTER ONCOLOGY
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, GmbH, HALLENVESTFALEN,
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, GERMANY
GUJARAT, INDIA GUJARAT, INDIA
Packer: INTAS PHARMACEUTICALS Packer: Packer:
INTAS PHARMACEUTICALS BAXTER ONCOLOGY
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, GmbH, HALLENVESTFALEN,
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, GERMANY
GUJARAT, INDIA GUJARAT, INDIA SCHERING-PLOUGH LABO
N.V., HEIST-OP-DEN-BERG,
BELGIUM
Laboratory: FPRC: INTAS PHARMACEUTICALS Laboratory: FPRC: INTAS PHARMACEUTICALS Laboratory: FPRC BAXTER ONCOLOGY
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, GmbH, HALLENVESTFALEN,
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, GERMANY
GUJARAT, INDIA GUJARAT, INDIA SCHERING-PLOUGH LABO
CONSULTING CHEMICAL CONSULTING CHEMICAL N.V., HEIST-OP-DEN-BERG,
LABORATORIES (PTY) LTD, LABORATORIES (PTY) LTD, BELGIUM
ATLASVILLE, BOKSBURG, RSA ATLASVILLE, BOKSBURG, CONSULTING CHEMICAL
RSA LABORATORIES,
ATLASVILLE, BOKSBURG,
RSA
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
KHULULEKANI
LABORATORY SERVICES,
COVENTRY PARK,
MIDRAND, RSA
FPRR: ACCORD HEALTHCARE (PTY) FPRR: FPRR:
ACCORD HEALTHCARE (PTY) SCHERING-PLOUGH,
LTD, RIVONIA, GAUTENG, RSA LTD, RIVONIA, GAUTENG, RSA WOODMEAD, SANDTON,
RSA
Shelf-life: 36 months Shelf-life: Shelf-life:
36 months 36 months
Date of registration: 26 OCTOBER 2012 Date of registration: Date of registration:
26 OCTOBER 2012 26 OCTOBER 2012
MRF 15 MRF15 MRF 15
Registration number: 43/18.3/0701 Registration number: 43/21.12/0726 Registration number: 43/2.6.5/0849
Name of medicine: SORBISTERIT POWDER FOR Name of medicine: LETOZ 2,5 TABLETS Name of medicine: PSYQUET 100
ORAL SUSPENSION
Dosage form: POWDER FOR ORAL Dosage form: TABLET Dosage form: TABLET
SUSPENSION
Active ingredients: EACH 1,0 g POWDER Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
CONTAINS: LETROZOLE 2,5 mg Quetiapine hemifumarate
CALCIUM POLYSTYRENE equivalent to Quetiapine 100,0 mg
SULPHONATE 7,59 - 9,49 g
Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8
Applicant: FRESENIUS KABI SA (PTY) LTD Applicant: ZYDUS HEALTHCARE SA (PTY) LTD Applicant: SANDOZ SA (PTY) LTD
Manufacturer: FRESENIUS MEDICAL CARE Manufacturer: ZYDUS CADILA HEALTHCARE Manufacturer: SANDOZ ILAC SANAYI VE
DEUTSCHLAND GmbH, ST. LIMITED, SANAND, AHMEDABAD, TICARET A.S, GEBZE-KOCAELI,
WENDEL, GERMANY INDIA TURKEY
Packer: FRESENIUS MEDICAL CARE Packer: ZYDUS CADILA HEALTHCARE Packer: SANDOZ ILAC SANAYI VE
DEUTSCHLAND GmbH, ST. LIMITED, SANAND, AHMEDABAD, TICARET A.S, GEBZE-KOCAELI,
WENDEL, GERMANY INDIA TURKEY
TECHNIKON LABORATORIES
(PTY) LTD, ROBERTVILLE,
FLORIDA, RSA
SANDOZ SA, SPARTAN,
KEMPTON PARK, RSA
Laboratory: FPRC: FRESENIUS MEDICAL CARE Laboratory: FPRC: ZYDUS CADILA HEALTHCARE Laboratory: FPRC SANDOZ ILAC SANAYI VE
DEUTSCHLAND GmbH, ST. LIMITED, SANAND, AHMEDABAD, TICARET A.S, GEBZE-KOCAELI,
WENDEL, GERMANY INDIA TURKEY
BODENE (PTY) LIMITED INSTITUTE FOR PHARMACEUTICAL CONSULTING CHEMICAL
TRADING AS INTRAMED, SERVICES, SILVERTONDALE, LABORATORIES (PTY) LTD,
KORSTEN, PORT ELIZABETH, PRETORIA, RSA ATLASVILLE, BOKSBURG, RSA
RSA INSTITUTE FOR INDUSTRIAL SABS COMMERCIAL (FTY) LTD
STAATSKOERANT, 6 FEBRUARIE 2013
0
No. 36136
19
20
MRF 15 MRF15 IF 15
Registration number: 43/2.6.5/0850 Registration number: 43/2.6.5/0851 Registration number: 43/2.6.5/0852
No. 36136
Name of medicine: PSYQUET 200 Name of medicine: PSYQUET 300 Name of medicine: SANDOZ QUETIAPINE 100
Dosage form: TABLET Dosage form: TABLET Dosage form: TABLET
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
Quetiapine hemifumarate equivalent Quetiapine hemifumarate equivalent Quetiapine hemifumarate
to Quetiapine 200,0 mg to Quetiapine 300,0 mg equivalent to Quetiapine
100,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: Conditions of registration:
2, 3, 4, 5, 6, 7, 8 1, 2, 3, 4, 5, 6, 7, 8
Applicant: SANDOZ SA (PTY) LTD Applicant: SANDOZ SA (PTY) LTD Applicant: SANDOZ SA (PTY) LTD
Manufacturer. SANDOZ ILAC SANAYI VE Manufacturer: SANDOZ ILAC SANAYI VE TICARET Manufacturer: SANDOZ ILAC SANAYI VE
TICARET AS, GEBZE-KOCAELI, AS, GEBZE-KOCAELI, TURKEY TICARET A.S, GEBZE-KOCAELI,
TURKEY TURKEY
Packer: SANDOZ ILAC SANAYI VE Packer: SANDOZ ILAC SANAYI VE TICARET Packer: SANDOZ ILAC SANAYI VE
TICARET A.S, GEBZE- KOCAELI, A.S, GEBZE-KOCAELI, TURKEY TICARET A.S, GEBZE-KOCAELI,
TURKEY TECHNIKON LABORATORIES TURKEY
TECHNIKON LABORATORIES LTD, ROBERTVILLE, TECHNIKON LABORATORIES
(PTY) LTD, ROBERTVILLE, RSA (PTY) LTD, ROBERTVILLE,
FLORIDA, RSA SANDOZ SA, SPARTAN, KEMPTON FLORIDA, RSA
SANDOZ SA, SPARTAN, RSA SANDOZ SA, SPARTAN,
KEMPTON PARK, RSA KEMPTON PARK, RSA
Laboratory: FPRC: SANDOZ ILAC SANAYI VE Laboratory: FPRC: SANDOZ ILAC SANAYI VE TICARET Laboratory: FPRC SANDOZ ILAC SANAYI VE
TICARET AS, GEBZE-KOCAELI, AS, GEBZE-KOCAELI, TURKEY TICARET AS, GEBZE-KOCAELI,
TURKEY CONSULTING CHEMICAL TURKEY
CONSULTING CHEMICAL (PTY) LTD, CONSULTING CHEMICAL
LABORATORIES (PTY) LTD, ATLASVILLE, BOKSBURG, RSA LABORATORIES (PTY) LTD,
ATLASVILLE, BOKSBURG, RSA COMMERCIAL (PTY) LTD ATLASVILLE, BOKSBURG, RSA
SABS COMMERCIAL (PTY) LTD CHEMISTRY SABS COMMERCIAL (PTY) LTD
PHARMACEUTICAL CHEMISTRY GROENKLOOF, PHARMACEUTICAL
DEPARTMENT GROENKLOOF, RSA CHEMISTRY DEPARTMENT
PRETORIA, RSA GROENKLOOF, PRETORIA,
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
RSA
FPRC/FPRR: SANDOZ SA (PTY) LTD, FPRC/FPRR: FPRC/FPRR:
SANDOZ SA (PTY) LTD, SPARTAN, SANDOZ SA (PTY) LTD,
SPARTAN, KEMPTON PARK, RSA PARK, RSA SPARTAN, KEMPTON PARK,
RSA
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH 1,0 ml CONTAINS:
Quetiapine hemifumarate equivalent to Quetiapine hemifumarate equivalent to THYROTROPIN ALFA 0,9 mg
Quetiapine 200,0 mg Quetiapine 300,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of 1, 2, 3, 4, 5, 6, 7
registration:
Applicant: SANDOZ SA (PTY) LTD Applicant: SANDOZ SA (PTY) LTD Applicant: GENZYME BIOPHARMACEUTICALS SA
(PTY)
Manufacturer: SANDOZ ILAC SANAYI VE TICARET Manufacturer: SANDOZ ILAC SANAYI VE TICARET Manufacturer: GENZYME CORPORATION, ALLSTON,
A.S, GEBZE-KOCAELI, TURKEY A.S, GEBZE-KOCAELI, TURKEY MASSACHUSETTS, USA
Packer: SANDOZ ILAC SANAYI VE TICARET Packer: SANDOZ ILAC SANAYI VE TICARET Packer: GENZYME CORPORATION, ALLSTON,
A.S, GEBZE-KOCAELI, TURKEY A.S, GEBZE-KOCAELI, TURKEY MASSACHUSETTS, USA
TECHNIKON LABORATORIES (PTY) TECHNIKON LABORATORIES (PTY)
LTD, ROBERTVILLE, FLORIDA, RSA LTD, ROBERTVILLE, FLORIDA, RSA
SANDOZ SA, SPARTAN, KEMPTON SANDOZ SA, SPARTAN, KEMPTON
PARK, RSA PARK, RSA
Laboratory: FPRC: SANDOZ ILAC SANAYI VE TICARET Laboratory: FPRC: SANDOZ ILAC SANAYI VE TICARET Laboratory: FPRC GENZYME CORPORATION, ALLSTON,
A.S, GEBZE-KOCAELI, TURKEY A.S, GEBZE-KOCAELI, TURKEY MASSACHUSETTS, USA
CONSULTING CHEMICAL CONSULTING CHEMICAL GENZYME CORPORATION, 45 NEW
LABORATORIES (PTY) LTD, LABORATORIES (PTY) LTD, YORK AVENUE, FRAMINGHAM,
ATLASVILLE, BOKSBURG, RSA ATLASVILLE, BOKSBURG, RSA MASSACHUSETTS, USA
SABS COMMERCIAL (PTY) LTD SABS COMMERCIAL (PTY) LTD GENZYME CORPORATION, 76 NEW
PHARMACEUTICAL CHEMISTRY PHARMACEUTICAL CHEMISTRY YORK AVENUE, FRAMINGHAM,
DEPARTMENT GROENKLOOF, DEPARTMENT GROENKLOOF, MASSACHUSETTS, USA
PRETORIA, RSA PRETORIA, RSA CONSULTING CHEMICAL
LABORATORIES, ATLASVILLE,
BOKSBURG, RSA
STAATSKOERANT, 6 FEBRUARIE 2013
FPRC/FPRR: SANDOZ SA (PTY) LTD, SPARTAN, FPRC/FPRR: SANDOZ SA (PTY) LTD, SPARTAN, FPRR: GENZYME BIOPHARMACEUTICALS SA
KEMPTON PARK, RSA KEMPTON PARK, RSA (PTY) LTD, BRYANSTON, GAUTENG, RSA
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
RANITIDINE HCI EQUIVALENT TO RANITIDINE HCI EQUIVALENT TO ATORVASTATIN CALCIUM
RANITIDINE 150,0 mg RANITIDINE 300,0 mg EQUIVALENT TO
ATORVASTATIN 10,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of 1, 2, 3, 4, 5, 6, 7, 8
registration:
Applicant: ARROW PHARMA SOUTH AFRICA Applicant ARROW PHARMA SOUTH AFRICA Applicant: ADCOCK INGRAM LIMITED
(PTY) LTD (PTY) LTD
Manufacturer: Rx MANUFACTURING INC, Manufacturer: Rx MANUFACTURING INC, Manufacturer: ACTAVIS hf,
MISSISSAUGA, ONTARIO, CANADA MISSISSAUGA, ONTARIO, CANADA HAFNARFJORDUR, ICELAND
ACTAVIS LTD, ZEJTUN,
MALTA
Packer. Rx MANUFACTURING INC, Packer: Rx MANUFACTURING INC, Packer: ACTAVIS hf,
MISSISSAUGA, ONTARIO, CANADA MISSISSAUGA, ONTARIO, CANADA HAFNARFJORDUR, ICELAND
TECHNIKON LABORATORIES (PTY) TECHNIKON LABORATORIES (PTY) ACTAVIS LTD, ZEJTUN,
LTD, ROBERTVILLE, FLORIDA, RSA LTD, ROBERTVILLE, FLORIDA, RSA MALTA
DIVPHARM MANUFACTURING AND DIVPHARM MANUFACTURING AND ADCOCK INGRAM
PACKAGING, LONGDALE, PACKAGING, LONGDALE, HEALTHCARE (PTY) LTD
INDUSTRIA, JOHANNESBURG, RSA INDUSTRIA, JOHANNESBURG, RSA (WADEVILLE), WADEVILLE,
GERMISTON, RSA
Laboratory: FPRC: RX MANUFACTURING INC, Laboratory: FPRC: RX MANUFACTURING INC, Laboratory: FPRC ACTAVIS hf,
MISSISSAUGA, ONTARIO, CANADA MISSISSAUGA, ONTARIO, CANADA HAFNARFJORDUR, ICELAND
TECHNIKON LABORATORIES (PTY) TECHNIKON LABORATORIES (PTY) ACTAVIS LTD, ZEJTUN,
LTD, ROBERTVILLE, FLORIDA, RSA LTD, ROBERTVILLE, FLORIDA, RSA MALTA
SEDEK AGRICHEM, KAMEELDRIFT- SEDEK AGRICHEM, KAMEELDRIFT-
EAST, PRETORIA, RSA EAST, PRETORIA, RSA
FPRR: ARROW PHARMA SOUTH AFRICA FPRR: ARROW PHARMA SOUTH AFRICA FPRC/FPRR: ADCOCK INGRAM
(PTY) LTD WOODMEAD, RSA (PTY) LTD WOODMEAD, RSA HEALTHCARE (PTY) LTD
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
( WADEVILLE), WADEVILLE,
GERMISTON, RSA
ADCOCK INGRAM LTD
(RESEARCH &
DEVELOPMENT), AEROTON,
JOHANNESBURG, RSA
Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional) FPRR: ADCOCK INGRAM LTD,
ERAND GARDENS,
MIDRAND, RSA
Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012 Shelf-life: 24 months (Provisional)
DEVELOPMENT), AEROTON,
JOHANNESBURG, RSA
FPRR: ADCOCK INGRAM LTD, ERAND FPRR: ADCOCK INGRAM LTD, ERAND FPRR: ADCOCK INGRAM LTD, ERAND
GARDENS, MIDRAND, RSA GARDENS, MIDRAND, RSA GARDENS, MIDRAND, RSA
Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional)
Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012
300399—C
MRF 15 MRF15 MMRF 15
Registration number: 43/7.5/1114 Registration number: 43/7.5/1115 Registration number: 43/7.5/1116
Name of medicine: RESTAN ATORVASTATIN 20 mg Name of medicine: RESTAN ATORVASTATIN 40 mg Name of medicine: ADCO ATORVASTATIN 10 mg
Dosage form: TABLET Dosage form: TABLET Dosage form: TABLET
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
ATORVASTATIN CALCIUM ATORVASTATIN CALCIUM ATORVASTATIN CALCIUM
EQUIVALENT TO EQUIVALENT TO EQUIVALENT TO
ATORVASTATIN 20,0 mg ATORVASTATIN 40,0 mg ATORVASTATIN 10,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8
Applicant: ADCOCK INGRAM LIMITED Applicant: ADCOCK INGRAM LIMITED ADCOCK INGRAM LIMITED
Applicant:
Manufacturer: ACTAVIS hf, HAFNARFJORDUR, Manufacturer: ACTAVIS hf, HAFNARFJORDUR, Manufacturer: ACTAVIS hf, HAFNARFJORDUR,
ICELAND ICELAND ICELAND
ACTAVIS LTD, ZEJTUN, MALTA ACTAVIS LTD, ZEJTUN, MALTA ACTAVIS LTD, ZEJTUN, MALTA
Packer: ACTAVIS hf, HAFNARFJORDUR, Packer: ACTAVIS hf, HAFNARFJORDUR, Packer: ACTAVIS hf, HAFNARFJORDUR,
ICELAND ICELAND ICELAND
ACTAVIS LTD, ZEJTUN, MALTA ACTAVIS LTD, ZEJTUN, MALTA ACTAVIS LTD, ZEJTUN, MALTA
ADCOCK INGRAM HEALTHCARE ADCOCK INGRAM HEALTHCARE ADCOCK INGRAM
(PTY) LTD ( WADEVILLE), (PTY) LTD (WADEVILLE), HEALTHCARE (PTY) LTD
WADEVILLE, GERMISTON, RSA WADEVILLE, GERMISTON, RSA (WADEVILLE), WADEVILLE,
GERMISTON, RSA
Laboratory: FPRC: ACTAVIS hf, HAFNARFJORDUR, Laboratory: FPRC: ACTAVIS hf, HAFNARFJORDUR, Laboratory: FPRC ACTAVIS hf, HAFNARFJORDUR,
ICELAND ICELAND ICELAND
ACTAVIS LTD, ZEJTUN, MALTA ACTAVIS LTD, ZEJTUN, MALTA ACTAVIS LTD, ZEJTUN, MALTA
FPRC/FPRR: ADCOCK INGRAM HEALTHCARE FPRC/FPRR: ADCOCK INGRAM HEALTHCARE FPRC/FPRR: ADCOCK INGRAM
(PTY) LTD (WADEVILLE), (PTY) LTD (WADEVILLE), HEALTHCARE (PTY) LTD
WADEVILLE, GERMISTON, RSA WADEVILLE, GERMISTON, RSA (WADEVILLE), WADEVILLE,
ADCOCK INGRAM LTD (RESEARCH ADCOCK INGRAM LTD GERMISTON, RSA
STAATSKOERANT, 6 FEBRUARIE 2013
MRF 15 MRF15 F 15
No. 36136
CHEMISTRY DEPARTMENT
GROENKLOOF, PRETORIA,
RSA
FPRC/FPRR: ADCOCK INGRAM HEALTHCARE FPRC/FPRR: ADCOCK INGRAM HEALTHCARE FPRR: GLENMARK
(PTY) LTD (WADEVILLE), (PTY) LTD (WADEVILLE), PHARMACEUTICALS SA
WADEVILLE, GERMISTON, RSA WADEVILLE, GERMISTON, RSA
ADCOCK INGRAM LTD (RESEARCH ADCOCK INGRAM LTD (PTY) LTD, MIDRAND, RSA
& DEVELOPMENT), AEROTON, (RESEARCH & DEVELOPMENT),
JOHANNESBURG, RSA AEROTON, JOHANNESBURG, RSA
FPRR: ADCOCK INGRAM LTD, ERAND FPRR: ADCOCK INGRAM LTD, ERAND Shelf-life: 24 months
GARDENS, MIDRAND, RSA GARDENS, MIDRAND, RSA
Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional) Date of registration: 26 OCTOBER 2012
Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012
No. 36136
27
28
Name of medicine: DOCETAXEL WINTHROP 20 Name of medicine: DOCETAXEL WINTHROP 80 Name of medicine: TAXOTERE 20 mg/1 ml RTU
mg/1 ml RTU mg/4 ml RTU
Dosage form: CONCENTRATE FOR Dosage form: CONCENTRATE FOR Dosage form: CONCENTRATE FOR SOLUTION
SOLUTION FOR INFUSION SOLUTION FOR INFUSION FOR INFUSION
Active ingredients: EACH 1,0 ml SOLUTION Active ingredients: EACH 4,0 ml SOLUTION Active ingredients: EACH 1,0 ml SOLUTION
CONTAINS: CONTAINS: CONTAINS:
DOCETAXEL TRIHYDRATE DOCETAXEL TRIHYDRATE DOCETAXEL TRIHYDRATE
EQUIVALENT TO EQUIVALENT TO EQUIVALENT TO
DOCETAXEL 20,0 mg DOCETAXEL 80,0 mg DOCETAXEL 20,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of 1, 2, 3, 4, 5, 6, 7, 8
registration:
Applicant: WINTHROP Applicant: WINTHROP Applicant: SANOFI-AVENTIS SA (PTY) LTD
PHARMACEUTICALS (PTY) LTD PHARMACEUTICALS (PTY)
LTD
Manufacturer: AVENTIS PHARMA Manufacturer: AVENTIS PHARMA Manufacturer: AVENTIS PHARMA DAGENHAM,
DAGENHAM, ESSEX, UNITED DAGENHAM, ESSEX, UNITED ESSEX, UNITED KINGDOM
KINGDOM KINGDOM
Packer: AVENTIS PHARMA Packer: AVENTIS PHARMA Packer: AVENTIS PHARMA DAGENHAM,
DAGENHAM, ESSEX, UNITED DAGENHAM, ESSEX, UNITED ESSEX, UNITED KINGDOM
KINGDOM KINGDOM
Laboratory: FPRC: AVENTIS PHARMA Laboratory: FPRC: AVENTIS PHARMA Laboratory: FPRC AVENTIS PHARMA DAGENHAM,
DAGENHAM, ESSEX, UNITED DAGENHAM, ESSEX, UNITED ESSEX, UNITED KINGDOM
KINGDOM KINGDOM M&L LABORATORY SERVICES,
M&L LABORATORY SERVICES, M&L LABORATORY LIMBRO BUSINESS PARK,
LIMBRO BUSINESS PARK, SERVICES, LIMBRO SANDTON, RSA
SANDTON, RSA BUSINESS PARK, SANDTON,
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
RSA
FPRR: WINTHROP FPRR: WINTHROP FPRR: SANOFI-AVENTIS SA (PTY) LTD,
PHARMACEUTICALS (PTY) PHARMACEUTICALS (PTY) MIDRAND, RSA
LTD, MIDRAND, RSA LTD, MIDRAND, RSA
Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional)
Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012
MRF 15 MRF15 IF 15
Registration number: 44/26/0101 Registration number 44/24/0102 Registration number: 44/13.12/0109
Name of medicine: TAXOTERE 80 mg/4 ml RTU Name of medicine: Name of medicine:
PHOSPHOSORB 660 EPIDUO 0,1 %/2,5 %
Dosage form: CONCENTRATE FOR SOLUTION Dosage form: TABLET Dosage form: GEL
FOR INFUSION
Active ingredients: EACH 4,0 ml SOLUTION CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH 1,0 g GEL CONTAINS:
DOCETAXEL TRIHYDRATE CALCIUM ACETATE 660,0 mg ADAPALENE 1,0 mg
EQUIVALENT TO BENZOYL PEROXIDE
DOCETAXEL 80,0 mg 25,0 mg
Conditions of registration: Conditions of registration: Conditions of registration:
1, 2, 3, 4, 5, 6, 7, 8 1, 2, 3, 4, 5, 6, 7 1, 2, 3, 4, 5, 6, 7
Applicant: SANOFI-AVENTIS SA (PTY) LTD Applicant: FRESENIUS KABI SA (PTY) Applicant: GALDERMA
LTD LABORATORIES S.A. (PTY)
LTD
Manufacturer. AVENTIS PHARMA DAGENHAM, Manufacturer. Manufacturer
FRESENIUS MEDICAL CARE LABORATOIRES
ESSEX, UNITED KINGDOM DEUTSCHLAND GmbH, BAD GALDERMA, MONTDESIR,
HOMBURG, GERMANY ALBY-SUR-CHERAN,
FRANCE
Packer: AVENTIS PHARMA DAGENHAM, Packer: Packer:
FRESENIUS MEDICAL CARE LABORATOIRES
ESSEX, UNITED KINGDOM DEUTSCHLAND GmbH, BAD GALDERMA, MONTDESIR,
HOMBURG, GERMANY ALBY-SUR-CHERAN,
FRANCE
Laboratory: FPRC: AVENTIS PHARMA DAGENHAM, Laboratory: FPRC: Laboratory: FPRC
FRESENIUS MEDICAL CARE LABORATOIRES
ESSEX, UNITED KINGDOM DEUTSCHLAND GmbH, BAD GALDERMA, MONTDESIR,
M&L LABORATORY SERVICES, HOMBURG, GERMANY ALBY-SUR-CHERAN,
LIMBRO BUSINESS PARK, FRANCE
SANDTON, RSA TECHNIKON
LABORATORIES (PTY) LTD,
ROBERTVILLE, FLORIDA,
STAATSKOERANT, 6 FEBRUARIE 2013
RSA
FPRR: FPRR: FPRR:
SANOFI-AVENTIS SA (PTY) LTD, FRESENIUS KABI SA (PTY) GALDERMA
MIDRAND, RSA LTD, HALFWAY HOUSE, LABORATORIES S.A.,
MIDRAND, RSA BRYANSTON,
JOHANNESBURG
Shelf -life: 24 months (Provisional) Shelf-life: Shelf-life:
24 months 36 months
In-use shelf life of 5 weeks
stored at or below 25 °C
Date of registration: 26 OCTOBER 2012 Date of registration: Date of registration:
26 OCTOBER 2012 26 OCTOBER 2012
No. 36136
29
30
MRF 15 MRF15 tF 15
Registration number: 44/3.1/0298 Registration number: 44/32.2/0546 Registration number: 44/10.3/0670
No. 36136
Name of medicine: VOLTAREN ACTI-GO SOFT GEL Name of medicine: Name of medicine:
MOZOBIL DAMS 500 pg
CAPSULE 25 mg
Dosage form: SOFT GEL CAPSULE Dosage form: SOLUTION FOR INJECTION Dosage form: TABLET
Active ingredients: EACH CAPSULE CONTAINS: Active ingredients: EACH VIAL CONTAINS: Active ingredients: EACH TABLET CONTAINS:
DICLOFENAC POTASSIUM PLERIXAFOR 20 mg/ml ROFLUMILAST 500,0 pg
25,0 mg
Conditions of registration: Conditions of registration: Conditions of registration:
1, 2, 3, 4, 5, 6, 7 1, 2, 3, 4, 5, 6, 7 1, 2, 3, 4, 5, 6, 7
Applicant: NOVARTIS SA (PTY) LTD Applicant: GENZYME Applicant: NYCOMED (PTY) LTD
BIOPHARMACEUTICALS
SOUTH AFRICA (PTY) LTD
Manufacturer: RP SCHERER GmbH & Co. KG, Manufacturer: Manufacturer:
PATHEON UK LTD, SWINDON, NYCOMED GmbH,
EBERBACH/BADEN, GERMANY WILTSHIRE, UNITED ORANIENBURG, GERMANY
KINGDOM
Packer: CATALENT GERMANY Packer: Packer:
PATHEON UK LTD, SWINDON, NYCOMED GmbH,
SCHORNDORF GmbH, WILTSHIRE, UNITED ORANIENBURG, GERMANY
STEINBEISSTRASSE, KINGDOM
SCHORNDORF, GERMANY GENZYME LTD, HAVERHILL,
SUFFOLK, UNITED KINGDOM
Laboratory: FPRC: RP SCHERER GmbH & Co. KG, Laboratory: FPRC: Laboratory: FPRC
PATHEON UK LTD, SWINDON, NYCOMED GmbH,
EBERBACH/BADEN, GERMANY WILTSHIRE, UNITED ORANIENBURG, GERMANY
SANDOZ SA (PTY) LTD, KINGDOM
SPARTAN, KEMPTON PARK, GENZYME LTD, HAVERHILL,
RSA SUFFOLK, UNITED KINGDOM
M & L LABORATORY CONSULTING CHEMICAL
SERVICES, LIMBRO BUSINESS LABORATORIES, ATLASVILLE,
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
BOKSBURG, RSA
FPRR: PHARMA DYNAMICS (PTY) FPRR: FPRR:
PHARMA DYNAMICS (PTY) PHARMA DYNAMICS (PTY)
LTD, SILVERWOOD CLOSE, LTD, SILVERWOOD CLOSE, LTD, SILVERWOOD CLOSE,
WESTLAKE, RSA WESTLAKE, RSA WESTLAKE, RSA
Shelf-life: 24 months (Provisional) Shelf-life: Shelf-life:
24 months (Provisional) 24 months (Provisional)
Date of registration: 26 OCTOBER 2012 Date of registration: Date of registration:
26 OCTOBER 2012 26 OCTOBER 2012
No. 36136
31
32
MRF 15 MRF15 MRF 15
Dosage form: POWDER FOR INJECTION Dosage form: POWDER FOR INJECTION Dosage form: CHEWABLE TABLET
Active ingredients: EACH VIAL CONTAINS: Active ingredients: EACH VIAL CONTAINS: Active ingredients: EACH CHEWABLE TABLET
CAPREOMYCIN SULPHATE CAPREOMYCIN SULPHATE CONTAINS:
EQUIVALENT TO EQUIVALENT TO Montelukast sodium
CAPREOMYCIN 1,0 g CAPREOMYCIN 1,0 g equivalent to Montelukast
4,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8
Applicant: CIPLA MEDPRO (PTY) LTD Applicant: CIPLA LIFE SCIENCES (PTY) Applicant: GLENMARK
LTD PHARMACEUTICALS SA
(PTY) LTD
Manufacturer: CIPLA LTD. (UNIT IX), VERNA, Manufacturer: CIPLA LTD. (UNIT IX), VERNA, Manufacturer: GLENMARK
GOA, INDIA GOA, INDIA PHARMACEUTICALS
LIMITED, BARDEZ, GOA,
INDIA
Packer: CIPLA LTD. (UNIT IX), VERNA, Packer: Packer: GLENMARK
CIPLA LTD. (UNIT IX), VERNA,
GOA, INDIA GOA, INDIA PHARMACEUTICALS
LIMITED, BARDEZ, GOA,
INDIA
Laboratory: FPRC: CIPLA LTD. (UNIT IX), VERNA, Laboratory: FPRC: CIPLA. LTD. (UNIT IX), VERNA, Laboratory: FPRC GLENMARK
GOA, INDIA GOA, INDIA PHARMACEUTICALS
LIMITED, BARDEZ, GOA,
INDIA
SABS COMMERCIAL (PTY)
LTD PHARMACEUTICAL
CHEMISTRY
DEPARTMENT;
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
GROENKLOOF, PRETORIA,
RSA
FPRR: CIPLA MEDPRO, ROSENPARK, FPRR: CIPLA LIFE SCIENCES, FPRR: GLENMARK
BELVILLE, RSA ROSENPARK, BELVILLE, RSA PHARMACEUTICALS SA
(PTY) LTD, MIDRAND, RSA
Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional)
Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012
MRF 15 MRF15 MRF 15
Name of medicine: GLENMONT 5 Name of medicine: GLENMONT 10 Name of medicine: MUCO GO 200 EFFERVESCENT
TABLETS
Dosage form: CHEWABLE TABLET Dosage form: TABLET Dosage form: EFFERVESCENT TABLET
Active ingredients: EACH CHEWABLE TABLET Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
CONTAINS: Montelukast sodium equivalent to ACETYLCYSTEINE 200,0 mg
Montelukast sodium equivalent to Montelukast 10,0 mg
Montelukast 5,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7
Applicant: GLENMARK PHARMACEUTICALS Applicant: GLENMARK PHARMACEUTICALS Applicant: ACTOR PHARMA (PTY) LTD
SA (PTY) LTD SA (PTY) LTD
Manufacturer: GLENMARK PHARMACEUTICALS Manufacturer: GLENMARK PHARMACEUTICALS Manufacturer: TEMMLER PHARMA GmbH & CO.
LIMITED, BARDEZ, GOA, INDIA LIMITED, BARDEZ, GOA, INDIA KG, MARBURG, GERMANY
Packer: GLENMARK PHARMACEUTICALS Packer: GLENMARK PHARMACEUTICALS Packer: TEMMLER PHARMA GmbH & CO.
LIMITED, BARDEZ, GOA, INDIA LIMITED, BARDEZ, GOA, INDIA KG, MARBURG, GERMANY
DIVPHARM MANUFACTURING AND
PACKAGING (PTY) LTD,
LONGDALE, INDUSTRIA, RSA
TECHNIKON LABORATORIES (PTY)
LTD, ROBERTVILLE, FLORIDA, RSA
Laboratory: FPRC: GLENMARK PHARMACEUTICALS Laboratory: FPRC: GLENMARK PHARMACEUTICALS Laboratory: FPRC TEMMLER PHARMA GmbH & CO.
LIMITED, BARDEZ, GOA, INDIA LIMITED, BARDEZ, GOA, INDIA KG, MARBURG, GERMANY
SABS COMMERCIAL (PTY) LTD SABS COMMERCIAL (PTY) LTD SABS COMMERCIAL (PTY) LTD
PHARMACEUTICAL CHEMISTRY PHARMACEUTICAL CHEMISTRY PHARMACEUTICAL CHEMISTRY
DEPARTMENT; GROENKLOOF, DEPARTMENT; GROENKLOOF, DEPARTMENT, GROENKLOOF,
PRETORIA, RSA PRETORIA, RSA PRETORIA, RSA
CONSULTING CHEMICAL
LABORATORIES (PTY) LTD,
ATLASVILLE, BOKSBURG, RSA
STAATSKOERANT, 6 FEBRUARIE 2013
Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional) Shelf-life: 60 months (Aluminium tubes)
36 months (Polyproylene containers)
Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012
No. 36136
33
34
MRF 15 MRF15
Dosage form: EFFERVESCENT TABLET Dosage form: TABLET Dosage form: CAPSULE
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH CAPSULE CONTAINS:
ACETYLCYSTEINE 200,0 mg LAMIVUDINE 150,0 mg ATAZANAVIR SULPHATE
EQUIVALENT TO
ATAZANAVIR 300,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1,2,3,4,5,6,7 Conditions of 1,2,3,4,5,6,7
registration:
Applicant ACTOR PHARMA (PTY) LTD Applicant WINTHROP PHARMACEUTICALS (PTY) Applicant: EMCURE PHARMACEUTICALS SA
LTD
(PTY) LTD
Manufacturer: TEMMLER PHARMA GmbH & CO. Manufacturer: HETERO DRUGS LIMITED, UNIT III, Manufacturer: EMCURE PHARMACEUTICALS INDIA,
KG, MARBURG, GERMANY JEEDIMETLA, HYDERABAD, INDIA HINJWADI, PUNE, INDIA
WINTHROP PHARMACEUTICALS (PTY)
LTD, WALTLOO, PRETORIA, RSA
Packer: TEMMLER PHARMA GmbH & CO. Packer: HETERO DRUGS LIMITED, UNIT III, Packer: EMCURE PHARMACEUTICALS INDIA,
KG, MARBURG, GERMANY JEEDIMETLA, HYDERABAD, INDIA HINJWADI, PUNE, INDIA
DIVPHARM MANUFACTURING AND WINTHROP PHARMACEUTICALS (PTY)
LTD, WALTLOO, PRETORIA, RSA
PACKAGING (PTY) LTD,
LONGDALE, INDUSTRIA, RSA
TECHNIKON LABORATORIES (PTY)
LTD, ROBERTVILLE, FLORIDA, RSA
Laboratory: FPRC: TEMMLER PHARMA GmbH & CO. Laboratory: FPRC: HETERO DRUGS LIMITED, UNIT III, Laboratory: FPRC: EMCURE PHARMACEUTICALS INDIA,
KG, MARBURG, GERMANY JEEDIMETLA, HYDERABAD, INDIA HINJWADI, PUNE, INDIA
SABS COMMERCIAL (PTY) LTD WINTHROP PHARMACEUTICALS (PTY)
CONSULTING CHEMICAL
LTD, WALTLOO, PRETORIA, RSA
PHARMACEUTICAL CHEMISTRY LABORATORIES, ATLASVILLE,
DEPARTMENT, GROENKLOOF, BOKSBURG, RSA
PRETORIA, RSA SEDEK AGRIKEM cc,
CONSULTING CHEMICAL SILVERTONDALE, PRETORIA, RSA
LABORATORIES (PTY) LTD, PHARMASPEC CONSULTING
ATLASVILLE, BOKSBURG, RSA LABORATORIES, FERNDALE,
TECHNIKON LABORATORIES (PTY) RANDBURG, RSA
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
Active ingredients: EACH CAPSULE CONTAINS: Active ingredients: EACH CAPSULE CONTAINS: Active ingredients: EACH CAPSULE
TEMOZOLOMIDE 250,0 mg TEMOZOLOMIDE 5,0 mg CONTAINS:
TEMOZOLOMIDE 20,0 mg
Conditions of 1, 2, 3, 4, 5, 6, 7, 8 Conditions of 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8
registration: registration:
Applicant: ACCORD HEALTHCARE (PTY) Applicant: ACCORD HEALTHCARE (PTY) Applicant: ACCORD HEALTHCARE
LTD LTD (PTY) LTD
Manufacturer: INTAS PHARMACEUTICALS Manufacturer: INTAS PHARMACEUTICALS Manufacturer: INTAS PHARMACEUTICALS
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, LIMITED, VILLAGE
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, MATODA, TALUKA,
GUJARAT, INDIA GUJARAT, INDIA AHMEDABAD, GUJARAT,
INDIA
Packer: INTAS PHARMACEUTICALS Packer: INTAS PHARMACEUTICALS Packer: INTAS PHARMACEUTICALS
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, LIMITED, VILLAGE
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, MATODA, TALUKA,
GUJARAT, INDIA GUJARAT, INDIA AHMEDABAD, GUJARAT,
INDIA
Laboratory: FPRC: INTAS PHARMACEUTICALS Laboratory: FPRC: INTAS PHARMACEUTICALS Laboratory: FPRC INTAS PHARMACEUTICALS
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, LIMITED, VILLAGE
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, MATODA, TALUKA,
GUJARAT, INDIA GUJARAT, INDIA AHMEDABAD, GUJARAT,
CONSULTING CHEMICAL CONSULTING CHEMICAL INDIA
LABORATORIES (PTY) LTD, LABORATORIES (PTY) LTD, CONSULTING CHEMICAL
ATLASVILLE, BOKSBURG, RSA ATLASVILLE, BOKSBURG, LABORATORIES (PTY) LTD,
PHARMASPEC CONSULTING RSA ATLASVILLE, BOKSBURG,
LABORATORIES, FERNDALE, PHARMASPEC CONSULTING RSA
RANDBURG, RSA LABORATORIES, FERNDALE, PHARMASPEC
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
MRF 15 MRF15 F 15
24 months 24 months
Date of registration: 26 OCTOBER 2012 Date of registration: Date of registration:
26 OCTOBER 2012 26 OCTOBER 2012
MRF 15 MRF15 MRF 15
Registration number: 45/2.6.5/0368 Registration number: 45/2.6.5/0369 Registration number: 45/2.6.5/0370
Name of medicine: CIPLA QUETIAPINE 150 Name of medicine: CIPLA QUETIAPINE 200 Name of medicine: CIPLA QUETIAPINE 300
Dosage form: TABLET Dosage form: TABLET Dosage form: TABLET
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
QUETIAPINE FUMARATE QUETIAPINE FUMARATE QUETIAPINE FUMARATE
EQUIVALENT TO QUETIAPINE EQUIVALENT TO QUETIAPINE EQUIVALENT TO QUETIAPINE
150,0 mg 200,0 mg 300,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of registration: Conditions of registration:
1, 2, 3, 4, 5, 6, 7 1, 2, 3, 4, 5, 6, 7
Applicant: CIPLA MEDPRO (PTY) LTD Applicant: CIPLA MEDPRO (PTY) LTD Applicant: CIPLA MEDPRO (PTY) LTD
Manufacturer: CIPLA LTD. (UNIT III), VERNA, Manufacturer: Manufacturer:
CIPLA LTD. (UNIT III), VERNA, CIPLA LTD. (UNIT III), VERNA,
SALCETTE, GOA, INDIA SALCETTE, GOA, INDIA SALCETTE, GOA, INDIA
Packer: CIPLA LTD. (UNIT III), VERNA, Packer: Packer:
CIPLA LTD. (UNIT III), VERNA, CIPLA LTD. (UNIT III), VERNA,
SALCETTE, GOA, INDIA SALCETTE, GOA, INDIA SALCETTE, GOA, INDIA
Laboratory: FPRC: CIPLA LTD (UNIT III), VERNA, Laboratory: FPRC: Laboratory: FPRC
CIPLA LTD. (UNIT III), VERNA, CIPLA LTD. (UNIT III), VERNA,
SALCETTE, GOA, INDIA SALCETTE, GOA, INDIA SALCETTE, GOA, INDIA
FPRR: CIPLA MEDPRO, ROSENPARK, FPRR: FPRR:
CIPLA MEDPRO, ROSENPARK, CIPLA MEDPRO, ROSENPARK,
BELVILLE, RSA BELVILLE, RSA BELVILLE, RSA
26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012 Date of registration: 26 OCTOBER 2012
No. 36136
41
42
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
NEVIRAPINE 200,0 mg LAMIVUDINE 150,0 mg LAMIVUDINE 300 mg
MYLAN (PTY) LTD, FPRR: MYLAN (PTY) LTD, FPRR: MYLAN (PTY) LTD,
MODDERFONTEIN, MODDERFONTEIN, MODDERFONTEIN,
JOHANNESBURG, RSA JOHANNESBURG, RSA JOHANNESBURG, RSA
MRF 15 MRF15 F 15
FPRR: MYLAN (PTY) LTD, MODDERFONTEIN, FPRR: HETERO DRUGS SA, JEAN PARK FPRR: WINTHROP PHARMACEUTICALS (PTY)
JOHANNESBURG, RSA CHAMBERS, CENTURION, RSA LTD, MIDRAND, RSA
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
LONDON, RSA
FPRR: PFIZER LABORATORIES (PTY) FPRR: FPRR:
LEBASI PHARMACEUTICALS PHARMACARE LIMITED,
LTD, SANDTON, RSA CC, POTCHEFSTROOM, RSA WOODMEAD, SANDTON, RSA
PHARMACARE LIMITED,
KORSTEN, PORT ELIZABETH,
RSA
Shelf-life: 36 months Shelf-life: Shelf-life:
24 months (Provisional) 24 months
Date of registration: 07 DECEMBER 2012 Date of registration: Date of registration:
07 DECEMBER 2012 07 DECEMBER 2012
No. 36136
45
46
Dosage form: TABLET Dosage form: POWDER AND SOLVENT FOR Dosage form: TABLET
INJECTABLE SOLUTION
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH VIAL CONTAINS: Active ingredients: EACH TABLET CONTAINS:
BISACODYL 5,0 mg SODIUM VALPROATE 400,0 mg CHLORPHENIRAMINE MALEATE
4,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7,8 Conditions of 1, 2, 3, 4, 5, 6, 7, 8
registration:
Applicant: PHARMACARE LIMITED Applicant: PHARMACARE LIMITED Applicant: PHARMACARE LIMITED
Manufacturer: PHARMACARE LIMITED, KORSTEN, Manufacturer: LABORATORIO REIG JOFRE S.A., SAN Manufacturer: PHARMACARE LIMITED, KORSTEN,
PORT ELIZABETH, RSA JOAN DESPI, BARCELONA, SPAIN PORT ELIZABETH, RSA
ASPEN PHARMACARE EAST ASPEN PHARMACARE EAST
LONDON, WILSONIA, EAST LONDON, LONDON (PTY) LTD, WILSONIA, EAST
RSA LONDON, RSA
Packer: PHARMACARE LIMITED, KORSTEN, Packer: LABORATORIO REIG JOFRE S.A., SAN Packer: PHARMACARE LIMITED, KORSTEN,
PORT ELIZABETH, RSA JOAN DESPI, BARCELONA, SPAIN PORT ELIZABETH, RSA
ASPEN PHARMACARE EAST ASPEN PHARMACARE EAST
LONDON, WILSONIA, EAST LONDON, LONDON (PTY) LTD, WILSONIA, EAST
RSA LONDON, RSA
Laboratory: FPRC: PHARMACARE LIMITED, KORSTEN, Laboratory: FPRC: LABORATORIO REIG JOFRE S.A., SAN
PORT ELIZABETH, RSA JOAN DESPI, BARCELONA, SPAIN Laboratory: FPRC: SABS COMMERCIAL (PTY) LTD
ASPEN PHARMACARE EAST RESEARCH INSTITUTE FOR INDUSTRIAL PHARMACEUTICAL CHEMISTRY
LONDON, WILSONIA, EAST LONDON, PHARMACY, NORTH-WEST UNIVERSITY, DEPARTMENT; GROENKLOOF,
RSA POTCHEFSTROOM PRETORIA, RSA
M&L LABORATORY SERVICES, LIMBRO M&L LABORATORY SERVICES,
BUSINESS PARK, SANDTON, RSA LIMBRO BUSINESS PARK, SANDTON,
SABS COMMERCIAL (PTY) LTD, RSA
PHARMACEUTICAL CHEMISTRY RESEARCH INSTITUTE FOR
DEPARTMENT, GROENKLOOF, INDUSTRIAL PHARMACY, NORTH-
PRETORIA, RSA WEST UNIVERSITY,
POTCHEFSTROOM, RSA
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
FPRR: PHARMACARE LIMITED, FPRC/FPRR: PHARMACARE LTD, KORSTEN, PORT FPRC/FPRR: PHARMACARE LIMITED, KORSTEN,
WOODMEAD, SANDTON, RSA ELIZABETH PORT ELIZABETH, RSA
ASPEN PHARMACARE EAST LONDON ASPEN PHARMACARE EAST
(PTY) LTD, WILSONIA, EAST LONDON, LONDON (PTY) LTD, WILSONIA, EAST
RSA LONDON, RSA
Shelf-life: 24 months FPRR: PHARMACARE LTD, WOODMEAD, FPRR: PHARMACARE LTD, WOODMEAD,
SANDTON SANDTON, RSA
Date of registration: 07 DECEMBER2012 Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional)
Name of medicine: SPEC-CIPROFLOXACIN 400 IV Name of medicine: FENOVENT Name of medicine: AUSTIGRAN 50
Dosage form: INJECTION Dosage form: LIQUID Dosage form: TABLET
Active ingredients: EACH 1,0 ml SOLUTION Active ingredients: EACH 5,0 ml CONTAINS: Active ingredients: EACH TABLET CONTAINS:
CONTAINS: FENOTEROL HYDROBROMIDE Sumatriptan succinate equivalent to
CIPROFLOXACIN LACTATE 2,5 mg Sumatriptan 50,0 mg
EQUIVALENT TO
CIPROFLOXACIN 2,0 mg
Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7
registration: registration:
AUSTELL LABORATORIES (PTY) LTD
Applicant: SPECPHARM (PTY) LTD Applicant: PHARMACARE LIMITED Applicant:
Manufacturer: ELPEN PHARMACEUTICAL CO. Manufacturer: PHARMACARE LIMITED, Manufacturer: IPCA LABORATORIES LIMITED, DADRA
INC, PIKERMI-ATTICA, GREECE KORSTEN, PORT ELIZABETH, RSA AND NAGAR HAVELI, INDIA
ASPEN PHARMACARE EAST
LONDON, WILSONIA, EAST
LONDON, RSA
Packer: ELPEN PHARMACEUTICAL CO. Packer: PHARMACARE LIMITED, Packer: IPCA LABORATORIES LIMITED, DADRA
INC, PIKERMI-ATTICA, GREECE KORSTEN, PORT ELIZABETH, RSA AND NAGAR HAVELI, INDIA
ASPEN PHARMACARE EAST
LONDON, WILSONIA, EAST
LONDON, RSA
Laboratory: FPRC: ELPEN PHARMACEUTICAL CO. Laboratory: FPRC: SABS COMMERCIAL (PTY) LTD Laboratory: FPRC IPCA LABORATORIES LIMITED, DADRA
INC, PIKERMI-ATTICA, GREECE PHARMACEUTICAL CHEMISTRY AND NAGAR HAVELI, INDIA
DEPARTMENT GROENKLOOF, SABS COMMERCIAL (PTY) LTD,
PRETORIA, RSA PHARMACEUTICAL CHEMISTRY
M & L LABORATORY SERVICES DEPARTMENT, GROENKLOOF, PRETORIA
(PTY) LTD, LIMBRO BUSINESS M&L LABORATORY SERVICES, LIMBRO
PARK, SANDTON, RSA BUSINESS PARK, SANDTON, RSA
RESEARCH INSTITUTE FOR INSTITUTE FOR PHARMACEUTICAL
INDUSTRIAL PHARMACY, NORTH SERVICES, SILVERTONDALE, PRETORIA,
STAATSKOERANT, 6 FEBRUARIE 2013
Name of medicine: AUSTIGRAN 100 Name of medicine: AUSTELL SUMATRIPTAN 50 mg Name of medicine: AUSTELL SUMATRIPTAN 100 mg
Dosage form: TABLET Dosage form: TABLET Dosage form: TABLET
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
Sumatriptan succinate equivalent to Sumatriptan succinate equivalent to Sumatriptan succinate equivalent
Sumatriptan 100,0 mg Sumatriptan 50,0 mg to Sumatriptan 100,0 mg
Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7
registration: registration:
Applicant: AUSTELL LABORATORIES (PTY) Applicant: AUSTELL LABORATORIES (PTY) Applicant: AUSTELL LABORATORIES (PTY)
LTD LTD LTD
Manufacturer: IPCA LABORATORIES LIMITED, Manufacturer: IPCA LABORATORIES LIMITED, Manufacturer: IPCA LABORATORIES LIMITED,
DADRA AND NAGAR HAVELI, DADRA AND NAGAR HAVELI, DADRA AND NAGAR HAVELI,
INDIA INDIA INDIA
Packer: IPCA LABORATORIES LIMITED, Packer: IPCA LABORATORIES LIMITED, Packer: IPCA LABORATORIES LIMITED,
DADRA AND NAGAR HAVELI, DADRA AND NAGAR HAVELI, DADRA AND NAGAR HAVELI,
INDIA INDIA INDIA
Laboratory: FPRC: IPCA LABORATORIES LIMITED, Laboratory: FPRC: IPCA LABORATORIES LIMITED, Laboratory: FPRC: IPCA LABORATORIES LIMITED,
DADRA AND NAGAR HAVELI, DADRA AND NAGAR HAVELI, DADRA AND NAGAR HAVELI,
INDIA INDIA INDIA
SABS COMMERCIAL (PTY) LTD, SABS COMMERCIAL (PTY) LTD, SABS COMMERCIAL (PTY) LTD,
PHARMACEUTICAL CHEMISTRY PHARMACEUTICAL CHEMISTRY PHARMACEUTICAL CHEMISTRY
DEPARTMENT, GROENKLOOF, DEPARTMENT, GROENKLOOF, DEPARTMENT, GROENKLOOF,
PRETORIA PRETORIA PRETORIA
M&L LABORATORY SERVICES, M&L LABORATORY SERVICES, M&L LABORATORY SERVICES,
LIMBRO BUSINESS PARK, LIMBRO BUSINESS PARK, LIMBRO BUSINESS PARK,
SANDTON, RSA SANDTON, RSA SANDTON, RSA
INSTITUTE FOR INSTITUTE FOR INSTITUTE FOR
PHARMACEUTICAL SERVICES, PHARMACEUTICAL SERVICES, PHARMACEUTICAL SERVICES,
SILVERTONDALE, PRETORIA, RSA SILVERTONDALE, PRETORIA, SILVERTONDALE, PRETORIA,
RSA RSA
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
FPRR: AUSTELL LABORATORIES (PTY) FPRR: AUSTELL LABORATORIES (PTY) FPRR AUSTELL LABORATORIES (PTY)
LTD, CROWN X3, LTD,CROWN X3, LTD, CROWN X3,
JOHANNESBURG, RSA JOHANNESBURG, RSA JOHANNESBURG, RSA
Date of registration: 07 DECEMBER 2012 Date of registration: 07 DECEMBER 2012 Date of registration: 07 DECEMBER 2012
MRF 15 MRF15 15
Dosage form: METERED DOSE INHALER Dosage form: STERILE POWDER FOR INJECTION Dosage form: STERILE POWDER FOR
INJECTION
Active ingredients: EACH METERED DOSE Active EACH VIAL CONTAINS: Active ingredients: EACH VIAL CONTAINS:
CONTAINS: ingredients: MEROPENEM TRIHYDRATE MEROPENEM TRIHYDRATE
IPRATROPIUM BROMIDE EQUIVALENT TO MEROPENEM EQUIVALENT TO
MONOHYDRATE ANHYDROUS 500,0 mg MEROPENEM ANHYDROUS
EQUIVALENT TO 1 000,0 mg
IPRATROPIUM BROMIDE
20,0 pg
SALBUTAMOL SULPHATE
EQUIVALENT TO
SALBUTAMOL 100,0 pg
Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7
registration: registration:
Applicant: CIPLA MEDPRO (PTY) LTD Applicant: PHARMA DYNAMICS (PTY) LTD Applicant: PHARMA DYNAMICS (PTY)
LTD
Manufacturer: CIPLA LIMITED GOA, UNIT (II), Manufacturer: DEMO S.A, ATHENS-LAMIA, ATHENS, Manufacturer: DEMO S.A, ATHENS-LAMIA,
VERNA , SALCETTE,GOA, GREECE ATHENS, GREECE
INDIA
Packer: CIPLA LIMITED GOA, UNIT (II), Packer: DEMO S.A, ATHENS-LAMIA, ATHENS, Packer: DEMO S.A, ATHENS-LAMIA,
VERNA , SALCETTE,GOA, GREECE ATHENS, GREECE
INDIA
Laboratory: FPRC: CIPLA LIMITED GOA, UNIT (II), Laboratory: DEMO S.A, ATHENS-LAMIA, ATHENS, Laboratory::FPRC DEMO S.A, ATHENS-LAMIA,
VERNA , SALCETTE,GOA, FPRC: GREECE ATHENS, GREECE
INDIA PHARMATHEN S.A, PALLINI, ATTIKIS, PHARMATHEN S.A, PALLINI,
GREECE ATTIKIS, GREECE
CONSULTING CHEMICAL CONSULTING CHEMICAL
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
Name of medicine: TRAMAL SR 50 mg Name of medicine: ASPEN CEFPODOXIME 100 Name of medicine: ASPEN CEFPODOXIME 200
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
TRAMADOL HCI 50,0 mg CEFPODOXIME PROXETIL EQUIVALENT TO CEFPODOXIME PROXETIL
CEFPODOXIME 100,0 mg EQUIVALENT TO
CEFPODOXIME 200,0 mg
Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8
registration: registration:
Applicant: JANSSEN PHARMACEUTICA (PTY) LTD Applicant: PHARMACARE LIMITED Applicant: PHARMACARE LIMITED
Manufacturer: FAMACEUTICI FORMENTI ITALY, Manufacturer: LUPIN LIMITED, MANDIDEEP, DISTRICT RAISEN, Manufacturer: LUPIN LIMITED, MANDIDEEP,
ORIGGIO, ITALY INDIA DISTRICT RAISEN, INDIA
GRUNENTHAL GmbH, STOLBERG, PHARMACARE LIMITED, KORSTEN, PORT PHARMACARE LIMITED, KORSTEN,
GERMANY ELIZABETH, RSA PORT ELIZABETH, RSA
ASPEN PHARMACARE EAST LONDON, ASPEN PHARMACARE EAST
WILSONIA, EAST LONDON, RSA LONDON, WILSONIA, EAST LONDON,
RSA
Packer: GRUNENTHAL GmbH, STOLBERG, Packer: LUPIN LIMITED, MANDIDEEP, DISTRICT RAISEN, Packer: LUPIN LIMITED, MANDIDEEP,
GERMANY INDIA DISTRICT RAISEN, INDIA
GRUNENTHAL GmbH, AACHEN, PHARMACARE LIMITED, KORSTEN, PORT PHARMACARE LIMITED, KORSTEN,
GERMANY ELIZABETH, RSA PORT ELIZABETH, RSA
SPECPHARM HOLDINGS (PTY) LTD, ASPEN PHARMACARE EAST LONDON, ASPEN PHARMACARE EAST
HALFWAY HOUSE, MIDRAND, RSA WILSONIA, EAST LONDON, RSA LONDON, WILSONIA, EAST LONDON,
RSA
Laboratory: FPRC: GRUNENTHAL GmbH, STOLBERG, Laboratory: FPRC: LUPIN LIMITED, MANDIDEEP, DISTRICT RAISEN, Laboratory: FPRC: LUPIN LIMITED, MANDIDEEP,
GERMANY INDIA DISTRICT RAISEN, INDIA
SPECPHARM HOLDINGS (PTY) LTD. SABS COMMERCIAL (PTY) LTD, SABS COMMERCIAL (PTY) LTD,
HALFWAY HOUSE, MIDRAND, RSA PHARMACEUTICAL CHEMISTRY DEPARTMENT, PHARMACEUTICAL CHEMISTRY
GROENKLOOF, PRETORIA, RSA DEPARTMENT, GROENKLOOF,
RESEARCH INSTITUTE FOR INDUSTRIAL PRETORIA, RSA
PHARMACY, NORTH-WEST UNIVERSITY, RESEARCH INSTITUTE FOR
POTCHEFSTROOM, RSA INDUSTRIAL PHARMACY, NORTH-
M&L LABORATORY SERVICES, LIMBRO WEST UNIVERSITY,
BUSINESS PARK, SANDTON, RSA POTCHEFSTROOM, RSA
STAATSKOERANT, 6 FEBRUARIE 2013
FPRR: JANSSEN PHARMACEUTICA (PTY) FPRC/FPRR: PHARMACARE LIMITED, KORSTEN, PORT FPRR: PHARMACARE LIMITED, KORSTEN,
LTD, WOODMEAD, JOHANNESBURG, ELIZABETH, RSA PORT ELIZABETH, RSA
RSA ASPEN PHARMACARE EAST LONDON, ASPEN PHARMACARE EAST
WILSONIA, EAST LONDON, RSA LONDON, WILSONIA, EAST LONDON,
RSA
Shelf-life: 36 months FPRR: PHARMACARE LIMITED, WOODMEAD, SANDTON, Shelf-life: PHARMACARE LIMITED, WOODMEAD,
RSA SANDTON, RSA
Date of registration: 07 DECEMBER2012 Shelf-life: 24 months (provisional) Date of registration: 24 months (provisional)
MRF 15 MRF15 F 15
No. 36136
WEST UNIVERSITY,
POTCHEFSTROOM, RSA
SABS COMMERCIAL (PTY) LTD
PHARMACEUTICAL CHEMISTRY
DEPARTMENT, GROENKLOOF,
PRETORIA, RSA
FPRR: TEVA PHARMACEUTICALS (PTY) FPRR: BODENE (PTY) LTD (TRADING FPRR: PHARMA DYNAMICS (PTY) LTD,
LTD, RUIMSIG, ROODEPORT, AS INTRAMED), KORSTEN, SILVERWOOD CLOSE, WESTLAKE, RSA
GAUTENG, RSA PORT ELIZABETH, RSA
Shelf-life: 36 months Shelf-life: 24 months Shelf-life: 24 months (Provisional)
Date of registration: 07 DECEMBER 2012 Date of registration: 07 DECEMBER 2012 Date of registration: 07 DECEMBER 2012
No. 36136
53
54
Manufacturer: LABORATORIOS CINFA S.A, Manufacturer: LABORATORIOS CINFA S.A, Manufacturer: LABORATORIOS CINFA S.A, HUARTE-
HUARTE-PAMPLONA, SPAIN HUARTE-PAMPLONA, SPAIN PAMPLONA, SPAIN
Packer: LABORATORIOS CINFA S.A, Packer: LABORATORIOS CINFA S.A, Packer: LABORATORIOS CINFA S.A, HUARTE-
HUARTE-PAMPLONA, SPAIN HUARTE-PAMPLONA, SPAIN PAMPLONA, SPAIN
Laboratory: FPRC: LABORATORIOS CINFA S.A, Laboratory: FPRC: LABORATORIOS CINFA S.A, Laboratory: FPRC: LABORATORIOS CINFA S.A, HUARTE-
HUARTE-PAMPLONA, SPAIN HUARTE-PAMPLONA, SPAIN PAMPLONA, SPAIN
CONSULTING CHEMICAL CONSULTING CHEMICAL CONSULTING CHEMICAL
LABORATORIES (PTY) LTD LABORATORIES (PTY) LTD LABORATORIES (PTY) LTD
ATLASVILLE, BOKSBURG, ATLASVILLE, BOKSBURG, RSA ATLASVILLE, BOKSBURG, RSA
RSA
FPRR: PHARMA DYNAMICS (PTY) FPRR: PHARMA DYNAMICS (PTY) LTD, FPRR: PHARMA DYNAMICS (PTY) LTD,
LTD, SILVERWOOD CLOSE, SILVERWOOD CLOSE, SILVERWOOD CLOSE, WESTLAKE,
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
RSA
FPRR: PHARMA DYNAMICS (PTY) FPRR: PHARMA DYNAMICS (PTY) FPRR: PHARMA DYNAMICS (PTY)
LTD, SILVERWOOD CLOSE, LTD, SILVERWOOD CLOSE, LTD, SILVERWOOD CLOSE,
WESTLAKE, RSA WESTLAKE, RSA WESTLAKE, RSA
Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional) Shelf-life: 24 months (Provisional)
Date of registration: 07 DECEMBER 2012 Date of registration: 07 DECEMBER 2012 Date of registration: 07 DECEMBER 2012
No. 36136
55
56
MRF 15 MRF 15
80 mg 500
Dosage form: TABLE Dosage form: TABLET Dosage form: TABLET
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
ATORVASTATIN CALCIUM MYCOPHENOLATE MYCOPHENOLATE MOFETIL
EQUIVALENT TO MOFETIL 500,0 mg 500,0 mg
ATORVASTATIN 80,0 mg
Conditions of registration: Conditions of registration: Conditions of
1, 2, 3, 4, 5, 6, 7, 8 1, 2, 3, 4, 5, 6, 7, 8 1, 2, 3, 4, 5, 6, 7, 8
registration:
Applicant: PHARMA DYNAMICS (PTY) Applicant: SANDOZ SA (PTY) LTD Applicant: SANDOZ SA (PTY) LTD
LTD
Manufacturer: LABORATORIOS CINFA S.A, Manufacturer: Manufacturer
SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED,
HUARTE-PAMPLONA, SPAIN KALWE, NAVI MUMBAI, KALWE, NAVI MUMBAI, INDIA
INDIA
Packer LABORATORIOS CINFA S.A, Packer: Packer:
SANDOZ PRIVATE LIMITED, SANDOZ PRIVATE LIMITED,
HUARTE-PAMPLONA, SPAIN KALWE, NAVI MUMBAI, KALWE, NAVI MUMBAI, INDIA
INDIA SANDOZ SA (PTY) LTD,
SANDOZ SA (PTY) LTD, SPARTAN, KEMPTON PARK,
SPARTAN, KEMPTON RSA
PARK, RSA
Laboratory: FPRC: LABORATORIOS CINFA S.A, Laboratory: FPRC: SANDOZ PRIVATE LIMITED, Laboratory: FPRC: SANDOZ PRIVATE LIMITED,
HUARTE-PAMPLONA, SPAIN KALWE, NAVI MUMBAI, KALWE, NAVI MUMBAI, INDIA
CONSULTING CHEMICAL INDIA SANDOZ SA (PTY) LTD,
LABORATORIES (PTY) LTD SANDOZ SA (PTY) LTD, SPARTAN, KEMPTON PARK,
ATLASVILLE, BOKSBURG, SPARTAN, KEMPTON RSA
RSA PARK, RSA SABS COMMERCIAL (PTY) LTD,
SABS COMMERCIAL (PTY) PHARMACEUTICAL
LTD, PHARMACEUTICAL CHEMISTRY DEPARTMENT,
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
ZI.OZ 2J3131A13030 LO :uoReils!6e.! ema ZI.OZ1:1391A1303C1 LO :uo!leils!6ei alea ZI.OZ H391/1303CILO :uoge.ils!6ai Jo area
(leuowtoid) sqluow VZ :31!1-11e4S (leuopvtoid) %Bum VZ :41-1191IS (IeUOIS!A0.1d) SLIWOW trZ :411184S
Vatd '14012:1111N30 VSU '14011:1111N30 `N1012:1111N30
`011 (Ald) (VS) AXV8NVJ CLLI (MA) (VS) AM/ON/VI:I (Ald) (VS) AWE:WW2:I
VSU 'CINVHCIR/1 YSU ICINNAIGRAJ
`>121Vd AU1N3A00 `>12:1Vd AU1N3A00
`S301A2f3S A2:101Y2109N/1 `S301AU3S AUO1tA/09Y1
STAATSKOERANT, 6 FEBRUARIE 2013
0
59
60
MRF 15 MRF15 RF 15
Active ingredients: EACH 44,9 g OF POWDER CONTAINS: Active ingredients: EACH 67,4 g OF POWDER CONTAINS: Active ingredients: EACH TABLET CONTAINS:
GENTAMICIN SULPHATE EQUIVALENT GENTAMICIN SULPHATE EQUIVALENT GLICLAZIDE 60,0 mg
TO GENTAMICIN 0,6 g TO GENTAMICIN 0,8 g
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8
Applicant: MC PHARMA (PTY) LTD Applicant: MC PHARMA (PTY) LTD Applicant: SERVIER LABORATORIES SA (PTY)
LTD
Manufacturer aap BIOMATERIALS GmbH & CO. KG, Manufacturer aap BIOMATERIALS GmbH & CO. KG, Manufacturer LES LABORATOIRES SERVIER
DIEBURG, GERMANY DIEBURG, GERMANY INDUSTRIE, GIDY, FRANCE
EMCM B.V, NIJMEGEN, THE EMCM B.V, NIJMEGEN, THE SERVIER (IRELAND) INDUSTRIES
NETHERLANDS NETHERLANDS LTD., ARKLOW, IRELAND
Packer: aap BIOMATERIALS GmbH &CO. KG, Packer: aap BIOMATERIALS GmbH & CO. KG, Packer: LES LABORATOIRES SERVIER
DIEBURG, GERMANY DIEBURG, GERMANY INDUSTRIE, GIDY, FRANCE
EMCM BM, NIJMEGEN, THE EMCM B.V, NIJMEGEN, THE SERVIER (IRELAND) INDUSTRIES
NETHERLANDS NETHERLANDS LTD., ARKLOW, IRELAND
BIOMET CEMENTING TECHNOLOGIES BIOMET CEMENTING TECHNOLOGIES MILLMOUNT HEALTHCARE LTD,
AB, SJOBO, SWEDEN AB, SJOBO, SWEDEN NAVAN, IRELAND
MILLMOUNT HEALTHCARE LTD,
DROGHEDA, IRELAND
TECHNIKON LABORATORIES (PTY)
LTD, ROBERTVILLE, FLORIDA, RSA
aap BIOMATERIALS GmbH & CO. KG, aap BIOMATERIALS GmbH & CO. KG,
Laboratory: FPRC: DIEBURG, GERMANY Laboratory FPRC: DIEBURG, GERMANY Laboratory: FPRC LES LABORATOIRES SERVIER
EMCM B.V, NIJMEGEN, THE EMCM B.V, NIJMEGEN, THE INDUSTRIE, GIDIE, FRANCE
NETHERLANDS NETHERLANDS SERVIER (IRELAND) INDUSTRIES
BIOMET CEMENTING TECHNOLOGIES BIOMET CEMENTING TECHNOLOGIES LTD., ARKLOW, IRELAND
AB, SJOBO, SWEDEN AB, SJOBO, SWEDEN TECHNIKON LABORATORIES (PTY)
BIOMET ORTHOPAEDICS BIOMET ORTHOPAEDICS LTD, ROBERTVILLE, FLORIDA, RSA
SWITZERLAND, KEZERS, SWITZERLAND, KEZERS, SWITZERLAND M & L LABORATORY SERVICES
SWITZERLAND ROSE MEDIZIN-UND (PTY) LTD, LIMBRO BUSINESS
ROSE MEDIZIN-UND STERILISIERTECHNIK GmbH, TRIER, PARK, SANDTON, RSA
STERILISIERTECHNIK GmbH, TRIER, GERMANY
GERMANY STERIGENICS, ZOETERMEER, THE
STERIGENICS, ZOETERMEER, THE NETHERLANDS
NETHERLANDS LABOR L&S AG, BAD BOCKLET-
LABOR L&S AG, BAD BOCKLET- GROSSENBRACH GERMANY
GROSSENBRACH GERMANY ACILAR AG, MORFELDEN-WALLDORF,
ACILAR AG, MORFELDEN-WALLDORF, GERMANY
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
FPRC/FPRR: MC PHARMA (PTY) LTD, MNANDI, FPRC/FPRR: MC PHARMA (PTY) LTD, MNANDI, FPRR:: SERVIER LABORATORIES SA (PTY)
WIERDAPARK, CENTURION, RSA WIERDAPARK, CENTURION, RSA LTD, WOODMEAD, JOHANNESBURG,
RSA
Shelf-life: 24 months (Provisional) Shelf -life: 24 months (Provisional) Shelf-life: 24 months (Provisional)
Date of registration: 07 DECEMBER 2012 Date of registration: 07 DECEMBER 2012 Date of registration: 07 DECEMBER 2012
MRF 15 MRF15 MRF 15
Dosage form: MODIFIED RELEASE TABLET Dosage form: MODIFIED RELEASE TABLET Dosage form: MODIFIED RELEASE TABLET
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
GLICLAZIDE 60,0 mg GLICLAZIDE 60,0 mg GLICLAZIDE 60,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of 1, 2, 3, 4, 5, 6, 7, 8
registration:
Applicant: EGIS PHARMACEUTICALS SA (PTY) Applicant: BIOGARAN SA (PTY) LTD Applicant: BIOGARAN SA (PTY) LTD
LTD
Manufacturer: LES LABORATOIRES SERVIER Manufacturer: LES LABORATOIRES SERVIER Manufacturer: LES LABORATOIRES SERVIER
INDUSTRIE, GIDY, FRANCE INDUSTRIE, GIDY, FRANCE INDUSTRIE, GIDY, FRANCE
SERVIER (IRELAND) INDUSTRIES SERVIER (IRELAND) INDUSTRIES LTD., SERVIER (IRELAND) INDUSTRIES LTD.,
LTD., ARKLOW, IRELAND ARKLOW, IRELAND ARKLOW, IRELAND
Packer: LES LABORATOIRES SERVIER Packer: LES LABORATOIRES SERVIER Packer: LES LABORATOIRES SERVIER
INDUSTRIE, GIDY, FRANCE INDUSTRIE, GIDY, FRANCE INDUSTRIE, GIDY, FRANCE
SERVIER (IRELAND) INDUSTRIES SERVIER (IRELAND) INDUSTRIES LTD., SERVIER (IRELAND) INDUSTRIES LTD.,
LTD., ARKLOW, IRELAND ARKLOW, IRELAND ARKLOW, IRELAND
MILLMOUNT HEALTHCARE LTD, MILLMOUNT HEALTHCARE LTD, MILLMOUNT HEALTHCARE LTD, NAVAN,
NAVAN, IRELAND NAVAN, IRELAND IRELAND
MILLMOUNT HEALTHCARE LTD, MILLMOUNT HEALTHCARE LTD, MILLMOUNT HEALTHCARE LTD,
DROGHEDA, IRELAND DROGHEDA, IRELAND DROGHEDA, IRELAND
TECHNIKON LABORATORIES (PTY) TECHNIKON LABORATORIES (PTY) TECHNIKON LABORATORIES (PTY) LTD,
LTD, ROBERTVILLE, FLORIDA, RSA LTD, ROBERTVILLE, FLORIDA, RSA ROBERTVILLE, FLORIDA, RSA
Laboratory: FPRC: LES LABORATOIRES SERVIER Laboratory: FPRC: LES LABORATOIRES SERVIER Laboratory: FPRC LES LABORATOIRES SERVIER
INDUSTRIE, GIDIE, FRANCE INDUSTRIE, GIDIE, FRANCE INDUSTRIE, GIDIE, FRANCE
SERVIER (IRELAND) INDUSTRIES SERVIER (IRELAND) INDUSTRIES LTD., SERVIER (IRELAND) INDUSTRIES LTD.,
LTD., ARKLOW, IRELAND ARKLOW, IRELAND ARKLOW, IRELAND
TECHNIKON LABORATORIES (PTY) TECHNIKON LABORATORIES (PTY) TECHNIKON LABORATORIES (PTY) LTD,
LTD, ROBERTVILLE, FLORIDA, RSA LTD, ROBERTVILLE, FLORIDA, RSA ROBERTVILLE, FLORIDA, RSA
STAATSKOERANT, 6 FEBRUARIE 2013
M & L LABORATORY SERVICES M & L LABORATORY SERVICES (PTY) M & L LABORATORY SERVICES (PTY)
(PTY) LTD, LIMBRO BUSINESS LTD, LIMBRO BUSINESS PARK, LTD, LIMBRO BUSINESS PARK,
PARK, SANDTON, RSA SANDTON, RSA SANDTON, RSA
FPRR: EGIS PHARMACEUTICALS SA (PTY) FPRC/FPRR: BIOGARAN SA (PTY) LTD, FPRR: BIOGARAN SA (PTY) LTD, WOODMEAD,
LTD, WOODMEAD, WOODMEAD, JOHANNESBURG, RSA JOHANNESBURG, RSA
JOHANNESBURG, RSA
Active ingredients: EACH VIAL CONTAINS: Active ingredients: EACH VIAL CONTAINS: Active ingredients: EACH TABLET CONTAINS
CISPLATIN 10,0 mg CISPLATIN 50,0 mg Pramipexole dihydrochloride
monohydrate equivalent to
Pramipexole 0,375 mg
Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7, 8
registration: registration: registration:
Applicant: ACCORD HEALTHCARE (PTY) Applicant: ACCORD HEALTHCARE Applicant: INGELHEIM
LTD (PTY) LTD PHARMACEUTICALS (PTY)
LTD
Manufacturer: INTAS PHARMACEUTICALS Manufacturer: INTAS PHARMACEUTICALS Manufacturer: BOEHRINGER INGELHEIM
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, PHARMA GmbH & Co. KG,
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, INGELHEIM am RHEIN,
GUJARAT, INDIA GUJARAT, INDIA GERMANY
Packer: INTAS PHARMACEUTICALS Packer: INTAS PHARMACEUTICALS Packer: BOEHRINGER INGELHEIM
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, PHARMA GmbH & Co. KG,
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, INGELHEIM am RHEIN,
GUJARAT, INDIA GUJARAT, INDIA GERMANY
Laboratory: FPRC: INTAS PHARMACEUTICALS Laboratory: FPRC: INTAS PHARMACEUTICALS Laboratory: FPRC BOEHRINGER INGELHEIM
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, PHARMA GmbH & Co. KG,
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, INGELHEIM am RHEIN,
GUJARAT, INDIA GUJARAT, INDIA GERMANY
CONSULTING CHEMICAL CONSULTING CHEMICAL PHAST GmbH,
LABORATORIES (PTY) LTD, LABORATORIES (PTY) LTD, HOMBURG/SAAR, GERMANY
ATLASVILLE, BOKSBURG, RSA ATLASVILLE, BOKSBURG,
PHARMASPEC CONSULTING RSA
LABORATORIES, FERNDALE, PHARMASPEC
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
Name of medicine: PEXOLA ER 4,5 mg Name of medicine: OZURDEX Name of medicine: YELATE 30
No. 36136
Dosage form: TABLET Dosage form: INTRAVITREAL IMPLANT Dosage form: CAPSULE
Active ingredients: EACH TABLET CONTAINS Active ingredients: EACH IMPLANT CONTAINS: Active ingredients: EACH CAPSULE CONTAINS:
Pramipexole dihydrochloride DEXAMETHASONE 700,0 pg Duloxetine hydrochloride equivalent to
monohydrate equivalent to Duloxetine 30,0 mg
Pramipexole 4,5 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of 1, 2, 3, 4, 5, 6, 7, 8 Conditions of 1, 2, 3, 4, 5, 6, 7
registration: registration:
Applicant: INGELHEIM PHARMACEUTICALS Applicant ALLERGAN PHARMACEUTICALS (PTY) Applicant: DR REDDY'S LABORATORIES (PTY)
(PTY) LTD LTD LTD
Manufacturer: BOEHRINGER INGELHEIM PHARMA Manufacturer: ALLERGAN PHARMACEUTICALS Manufacturer: DR REDDY'S LABORATORIES LIMITED,
GmbH & Co. KG, INGELHEIM am IRELAND, WESTPORT, COUNTY MAYO, QUTHUBULLAPUR MANDAL, RANGA
RHEIN, GERMANY IRELAND REDDY DISTRICT, ANDHRA PRADESH,
INDIA
Packer: BOEHRINGER INGELHEIM PHARMA Packer: ALLERGAN PHARMACEUTICALS Packer: DR REDDY'S LABORATORIES LIMITED,
GmbH & Co. KG, INGELHEIM am IRELAND, WESTPORT, COUNTY MAYO, QUTHUBULLAPUR MANDAL, RANGA
RHEIN, GERMANY IRELAND REDDY DISTRICT, ANDHRA PRADESH,
INDIA
DRA PHARMACEUTICALS, IRENE,
CENTURION, RSA
TECHNIKON LABORATORIES (PTY)
LTD, ROBERTVILLE, FLORIDA, RSA
DIVPHARM MANUFACTURING AND
PACKAGING (PTY) LTD, LONGDALE,
INDUSTRIA, RSA
Laboratory: FPRC: BOEHRINGER INGELHEIM PHARMA Laboratory: FPRC: ALLERGAN PHARMACEUTICALS Laboratory: FPRC DR REDDY'S LABORATORIES LIMITED,
GmbH & Co. KG, INGELHEIM am IRELAND, WESTPORT, COUNTY MAYO, QUTHUBULLAPUR MANDAL, RANGA
RHEIN, GERMANY IRELAND REDDY DISTRICT, ANDHRA PRADESH,
PHAST GmbH, HOMBURG/SAAR, INSTITUTE FOR PHARMACEUTICAL INDIA
GERMANY SERVICES, SILVERTONDALE, INSTITUTE FOR PHARMACEUTICAL
PRETORIA, RSA SERVICES, SILVERTONDALE,
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
PRETORIA, RSA
RESEARCH INSTITUTE FOR
INDUSTRIAL PHARMACY, NORTH-
WEST UNIVERSITY, POTCHEFSTROOM,
RSA
FPRR: INGELHEIM PHARMACEUTICALS FPRR: ALLERGAN PHARMACEUTICALS (PTY) FPRR: DR REDDY'S LABORATORIES (PTY)
(PTY) LTD, FENDALE, RANDBURG, LTD, RANDJESPARK EXT. 11, MIDRAND, LTD, THE PLACE, SANDTON, RSA
RSA RSA
INSTITUTE FOR
PRETORIA, RSA PHARMACEUTICAL SERVICES, PHARMACEUTICAL SERVICES,
RESEARCH INSTITUTE FOR SILVERTONDALE, PRETORIA, RSA SILVERTONDALE, PRETORIA,
INDUSTRIAL PHARMACY, NORTH- RESEARCH INSTITUTE FOR RSA
WEST UNIVERSITY, INDUSTRIAL PHARMACY, NORTH- RESEARCH INSTITUTE FOR
POTCHEFSTROOM, RSA WEST UNIVERSITY, INDUSTRIAL PHARMACY,
POTCHEFSTROOM, RSA NORTH-WEST UNIVERSITY,
POTCHEFSTROOM, RSA
FPRC DR REDDY'S LABORATORIES (PTY) FPRR: DR REDDY'S LABORATORIES FPRR: DR REDDY'S LABORATORIES
LTD, THE PLACE, SANDTON, RSA (PTY) LTD, THE PLACE, SANDTON, (PTY) LTD, THE PLACE,
RSA SANDTON, RSA
MRF 15 MRF15 F 15
Dosage form: TABLET Dosage form: CONCENTRATE FOR SOLUTION Dosage form: CONCENTRATE FOR SOLUTION
FOR INFUSION FOR INFUSION
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH VIAL CONTAINS: Active ingredients: EACH VIAL CONTAINS:
DASATINIB 100,0 mg DOCETAXEL 20,0 mg DOCETAXEL 80,0 mg
Conditions of registration: Conditions of registration: Conditions of
1, 2, 3, 4, 5, 6, 7, 8 1, 2, 3, 4, 5, 6, 7, 8 1, 2, 3, 4, 5, 6, 7, 8
registration:
Applicant: BRISTOL-MYERS SQUIBB (PTY) Applicant: ACCORD HEALTHCARE (PTY) LTD Applicant: ACCORD HEALTHCARE (PTY) LTD
LTD
Manufacturer: BRISTOL-MYERS SQUIBB Manufacturer: Manufacturer:
INTAS PHARMACEUTICALS INTAS PHARMACEUTICALS
COMPANY, MT VERNON, INDIANA, LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA,
USA TALUKA, AHMEDABAD, GUJARAT, TALUKA, AHMEDABAD, GUJARAT,
INDIA INDIA
Packer: BRISTOL-MYERS SQUIBB Packer. Packer:
INTAS PHARMACEUTICALS INTAS PHARMACEUTICALS
COMPANY, MT VERNON, INDIANA, LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA,
USA TALUKA, AHMEDABAD, GUJARAT, TALUKA, AHMEDABAD, GUJARAT,
BRISTOL-MYERS SQUIBB INDIA INDIA
COMPANY, EPERNON, FRANCE
BRISTOL-MYERS SQUIBB S.R.L,
ANAGNI, ITALY
Laboratory: FPRC: BRISTOL-MYERS SQUIBB Laboratory: FPRC: INTAS PHARMACEUTICALS Laboratory: FPRC INTAS PHARMACEUTICALS
COMPANY, EPERNON, FRANCE LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA,
BRISTOL-MYERS SQUIBB S.R.L, TALUKA, AHMEDABAD, GUJARAT, TALUKA, AHMEDABAD, GUJARAT,
ANAGNI, ITALY INDIA INDIA
CONSULTING CHEMICAL CONSULTING CHEMICAL CONSULTING CHEMICAL
LABORATORIES (PTY) LTD, LABORATORIES (PTY) LTD, LABORATORIES (PTY) LTD,
ATLASVILLE, BOKSBURG, RSA ATLASVILLE, BOKSBURG, RSA ATLASVILLE, BOKSBURG, RSA
NKUNZI PHARMACEUTICALS (PTY) PHARMASPEC CONSULTING PHARMASPEC CONSULTING
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
Dosage form: SOLUTION FOR INJECTION Dosage form: TABLET Dosage form: TABLET
Active ingredients: EACH VIAL CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
WATER FOR INJECTION ESCITALOPRAM OXALATE ESCITALOPRAM OXALATE
q.s 1,0 ml EQUIVALENT TO EQUIVALENT TO
POLYETHYLENE GLYCOL 400 ESCITALOPRAM 10,0 mg ESCITALOPRAM 20,0 mg
130,0 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7, 8 Conditions of 1, 2, 3, 4, 5, 6, 7, 8
registration:
Applicant: ACCORD HEALTHCARE (PTY) Applicant ACCORD HEALTHCARE (PTY) Applicant: ACCORD HEALTHCARE (PTY)
LTD LTD LTD
Manufacturer: INTAS PHARMACEUTICALS Manufacturer: INTAS PHARMACEUTICALS Manufacturer: INTAS PHARMACEUTICALS
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA,
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, TALUKA, AHMEDABAD,
GUJARAT, INDIA GUJARAT, INDIA GUJARAT, INDIA
Packer: INTAS PHARMACEUTICALS Packer: INTAS PHARMACEUTICALS Packer: INTAS PHARMACEUTICALS
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA,
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, TALUKA, AHMEDABAD,
GUJARAT, INDIA GUJARAT, INDIA GUJARAT, INDIA
Laboratory: FPRC: INTAS PHARMACEUTICALS Laboratory: FPRC: INTAS PHARMACEUTICALS Laboratory: FPRC INTAS PHARMACEUTICALS
LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA, LIMITED, VILLAGE MATODA,
TALUKA, AHMEDABAD, TALUKA, AHMEDABAD, TALUKA, AHMEDABAD,
GUJARAT, INDIA GUJARAT, INDIA GUJARAT, INDIA
CONSULTING CHEMICAL CONSULTING CHEMICAL CONSULTING CHEMICAL
LABORATORIES (PTY) LTD, LABORATORIES (PTY) LTD, LABORATORIES (PTY) LTD,
ATLASVILLE, BOKSBURG, RSA ATLASVILLE, BOKSBURG, ATLASVILLE, BOKSBURG, RSA
PHARMASPEC CONSULTING RSA PHARMASPEC CONSULTING
LABORATORIES, FERNDALE, PHARMASPEC CONSULTING LABORATORIES, FERNDALE,
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
INJECTION
Active ingredients: EACH 1,0 ml SOLUTION Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
CONTAINS: QUETIAPINE FUMARATE QUETIAPINE FUMARATE
ROMIPLOSTIM 500,0 pg EQUIVALENT TO QUETIAPINE EQUIVALENT TO
25,0 mg QUETIAPINE 100,0 mg
Conditions of registration: Conditions of registration: Conditions of registration:
1, 2, 3, 4, 5, 6, 7 1, 2, 3, 4, 5, 6, 7, 8 1, 2, 3, 4, 5, 6, 7, 8
Applicant: BATSWADI Applicant: SUN PHARMACEUTICALS SA Applicant: SUN PHARMACEUTICALS
PHARMACEUTICALS (PTY) LTD (PTY) LTD SA (PTY) LTD
Manufacturer. Manufacturer: Manufacturer:
PATHEON S.p.A, MONZA, ITALY SUN PHARMACEUTICALS SUN PHARMACEUTICALS
INDUSTRIES LIMITED, DADRA INDUSTRIES LIMITED,
& NAGAR HAVELI, INDIA DADRA & NAGAR HAVELI,
INDIA
Packer: AMGEN EUROPE BV (ABR), Packer Packer
SUN PHARMACEUTICALS SUN PHARMACEUTICALS
BREDA, THE NETHERLANDS INDUSTRIES LIMITED, DADRA INDUSTRIES LIMITED,
& NAGAR HAVELI, INDIA DADRA & NAGAR HAVELI,
INDIA
Laboratory: FPRC: AMGEN EUROPE BV (ABR), Labdratory: FPRC: SUN PHARMACEUTICALS Laboratory: FPRC SUN PHARMACEUTICALS
BREDA, THE NETHERLANDS INDUSTRIES LIMITED, DADRA INDUSTRIES LIMITED,
& NAGAR HAVELI, INDIA DADRA & NAGAR HAVELI,
CONSULTING CHEMICAL INDIA
LABORATORIES, ATLASVILLE, CONSULTING CHEMICAL
BOKSBURG, RSA LABORATORIES,
RESEARCH INSTITUTE FOR ATLASVILLE, BOKSBURG,
INDUSTRIAL PHARMACY, RSA
NORTH WEST UNIVERSITY, RESEARCH INSTITUTE
POTCHEFSTROOM, RSA FOR INDUSTRIAL
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
NEVIRAPINE (ANHYDROUS) 100 mg NEVIRAPINE (ANHYDROUS) NEVIRAPINE (ANHYDROUS)
400 mg 50 mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7
Applicant INGELHEIM PHARMACEUTICALS Applicant: INGELHEIM PHARMACEUTICALS Applicant: INGELHEIM
(PTY) LTD (PTY) LTD PHARMACEUTICALS (PTY) LTD
Manufacturer: BOEHRINGER INGELHEIM ROXANE Manufacturer: BOEHRINGER INGELHEIM Manufacturer: BOEHRINGER INGELHEIM
INC, WILSON ROAD, COLUMBUS, ROXANE INC, WILSON ROAD, ROXANE INC, WILSON ROAD,
OHIO, USA COLUMBUS, OHIO, USA COLUMBUS, OHIO, USA
Packer: BOEHRINGER INGELHEIM ROXANE Packer: BOEHRINGER INGELHEIM Packer: BOEHRINGER INGELHEIM
INC, WILSON ROAD, COLUMBUS, ROXANE INC, WILSON ROAD, ROXANE INC, WILSON ROAD,
OHIO, USA COLUMBUS, OHIO, USA COLUMBUS, OHIO, USA
SIXARP, LLC - PRAXIS PACKAGING SIXARP, LLC - PRAXIS SIXARP, LLC - PRAXIS
SOLUTIONS, GRAND RAPIDS, PACKAGING SOLUTIONS, GRAND PACKAGING SOLUTIONS,
MICHIGAN, USA RAPIDS, MICHIGAN, USA GRAND RAPIDS, MICHIGAN,
SIXARP, LLC - PRAXIS PACKAGING SIXARP, LLC - PRAXIS USA
SOLUTIONS, COLUMBUS, OHIO, PACKAGING SOLUTIONS, SIXARP, LLC - PRAXIS
USA COLUMBUS, OHIO, USA PACKAGING SOLUTIONS,
DRA PHARMACEUTICALS, IRENE, DRA PHARMACEUTICALS, IRENE, COLUMBUS, OHIO, USA
PRETORIA, RSA PRETORIA, RSA DRA PHARMACEUTICALS,
IRENE, PRETORIA, RSA
Laboratory: FPRC: BOEHRINGER INGELHEIM ROXANE Laboratory: FPRC: BOEHRINGER INGELHEIM Laboratory: FPRC BOEHRINGER INGELHEIM
INC., WILSON ROAD, COLUMBUS, ROXANE INC., WILSON ROAD, ROXANE INC., WILSON ROAD,
OHIO, USA COLUMBUS, OHIO, USA COLUMBUS, OHIO, USA
BOEHRINGER INGELHEIM ROXANE BOEHRINGER INGELHEIM BOEHRINGER INGELHEIM
INC., OAK STREET, COLUMBUS, ROXANE INC., OAK STREET, ROXANE INC., OAK STREET,
OHIO, USA COLUMBUS, OHIO, USA COLUMBUS, OHIO, USA
RESEARCH INSTITUTE FOR RESEARCH INSTITUTE FOR RESEARCH INSTITUTE FOR
INDUSTRIAL PHARMACY, NORTH INDUSTRIAL PHARMACY, NORTH INDUSTRIAL PHARMACY,
WEST UNIVERSITY, WEST UNIVERSITY, NORTH WEST UNIVERSITY,
POTCHEFSTROOM, RSA POTCHEFSTROOM, RSA POTCHEFSTROOM, RSA
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
Dosage form: MODIFIED RELEASE TABLET Dosage form: MODIFIED RELEASE TABLET Dosage form: TABLET
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH TABLET CONTAINS:
NEVIRAPINE (ANHYDROUS) 100 mg NEVIRAPINE (ANHYDROUS) 400 mg Tenofovir disoproxil fumarate
300,0mg
Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7
registration: registration:
Applicant: INGELHEIM PHARMACEUTICALS (PTY) Applicant INGELHEIM PHARMACEUTICALS (PTY) Applicant: MYLAN (PTY) LTD
LTD LTD
Manufacturer: BOEHRINGER INGELHEIM ROXANE Manufacturer: BOEHRINGER INGELHEIM ROXANE Manufacturer: MATRIX LABORATORIES LIMITED,
INC, WILSON ROAD, COLUMBUS, INC, WILSON ROAD, COLUMBUS, SINNAR,NASHIK, MAHARASHTRA,
OHIO, USA OHIO, USA INDIA
Packer: BOEHRINGER INGELHEIM ROXANE Packer: BOEHRINGER INGELHEIM ROXANE Packer: MATRIX LABORATORIES LIMITED,
INC, WILSON ROAD, COLUMBUS, INC, WILSON ROAD, COLUMBUS, S I NNAR, NASHIK, MAHARASHTRA,
OHIO, USA OHIO, USA INDIA
SIXARP, LLC - PRAXIS PACKAGING SIXARP, LLC - PRAXIS PACKAGING
SOLUTIONS, GRAND RAPIDS, SOLUTIONS, GRAND RAPIDS,
MICHIGAN, USA MICHIGAN, USA
SIXARP, LLC - PRAXIS PACKAGING SIXARP, LLC - PRAXIS PACKAGING
SOLUTIONS, COLUMBUS, OHIO, USA SOLUTIONS, COLUMBUS, OHIO, USA
DRA PHARMACEUTICALS, IRENE, DRA IRENE,
PRETORIA, RSA PRETORIA, RSA
Laboratory: FPRC: BOEHRINGER INGELHEIM ROXANE Laboratory: FPRC: BOEHRINGER INGELHEIM ROXANE Laboratory: FPRC MATRIX LABORATORIES LIMITED,
INC., WILSON ROAD, COLUMBUS, INC., WILSON ROAD, COLUMBUS, SINNAR,NASHIK, MAHARASHTRA,
OHIO, USA OHIO, USA INDIA
BOEHRINGER INGELHEIM ROXANE BOEHRINGER INGELHEIM ROXANE
INC., OAK STREET, COLUMBUS, OHIO, ,
CONSULTING CHEMICAL
INC OAK STREET, COLUMBUS, OHIO,
USA USA LABORATORIES, ATLASVILLE,
RESEARCH INSTITUTE FOR RESEARCH INSTITUTE FOR BOKSBURG, RSA
INDUSTRIAL PHARMACY, NORTH INDUSTRIAL PHARMACY, NORTH ACORN PHARMACEUTICALS (PTY)
WEST UNIVERSITY, WEST UNIVERSITY, LTD, NORTH RIDING,
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
CONSULTING
LABORATORIES,
FERNDALE, RANDBURG,
RSA
FPRR: MACLEODS PHARMACEUTICALS FPRR: FPRR:
MYLAN (PTY) LTD, MYLAN (PTY) LTD,
SA (PTY) LTD, HALFWAY HOUSE, MODDERFONTEIN,
MIDRAND, RSA
MODDERFONTEIN,
JOHANNESBURG, RSA JOHANNESBURG, RSA
Shelf-life: 24 months (Provisional) Shelf-life: 24 months Shelf-life: 24 months
Date of registration: 07 DECEMBER 2012 Date of registration: 07 DECENBER 2012 Date of registration: 07 DECENBER 2012
No. 36136
75
76
MRF 15 MRF15 MRF 15
INFUSION
Active ingredients: EACH TABLET CONTAINS: Active ingredients: EACH VIAL CONTAINS: Active ingredients: EACH VIAL CONTAINS:
EFAVIRENZ 200,0 mg TRASTUZUMAB 440,0 mg Bacteriostatic water for injection
20,0 ml
Conditions of registration: 1, 2, 3, 4, 5, 6, 7 Conditions of 1, 2, 3, 4, 5, 6, 7 Conditions of registration: 1, 2, 3, 4, 5, 6, 7
registration:
Applicant: MYLAN (PTY) LTD Applicant ROCHE PRODUCTS (PTY) LTD Applicant: ROCHE PRODUCTS (PTY) LTD
Manufacturer: MATRIX LABORATORIES LIMITED, Manufacturer: GENENTECH INC., SOUTH SAN Manufacturer: F. HOFFMANN-LA ROCHE LTD,
SINNAR,NASHIK, MAHARASHTRA, FRANCISCO, CALIFORNIA, USA KAISERAUGST SWITZERLAND
INDIA GENENTECH INC., VACAVILLE, F. HOFFMANN-LA ROCHE LTD,
CALIFORNIA, USA BASEL, SWITZERLAND
Packer: MATRIX LABORATORIES LIMITED, Packer: GENENTECH INC., SOUTH SAN Packer: F. HOFFMANN-LA ROCHE LTD,
SINNAR,NASHIK, MAHARASHTRA, FRANCISCO, CALIFORNIA, USA KAISERAUGST SWITZERLAND
INDIA GENENTECH INC., VACAVILLE, F. HOFFMANN-LA ROCHE LTD,
CALIFORNIA, USA BASEL, SWITZERLAND
F. HOFFMANN-LA ROCHE LTD, GP GRENZACH
KAISERAUGST SWITZERLAND PRODUCTIONS, GRENZACH-
AKACIA HEALTH CARE (PTY) LTD, WYHLEN, SWITZERLAND
ISANDO, JOHANNESBURG, RSA AKACIA HEALTH CARE (PTY)
LTD, ISANDO,
JOHANNESBURG, RSA
Laboratory: FPRC: MATRIX LABORATORIES LIMITED, Laboratory: FPRC: GENENTECH INC., SOUTH SAN Laboratory: FPRC F. HOFFMANN-LA ROCHE LTD,
SINNAR,NASHIK, MAHARASHTRA, FRANCISCO, CALIFORNIA, USA KAISERAUGST SWITZERLAND
INDIA F. HOFFMANN-LA ROCHE LTD, F. HOFFMANN-LA ROCHE LTD,
CONSULTING CHEMICAL KAISERAUGST SWITZERLAND BASEL, SWITZERLAND
LABORATORIES, ATLASVILLE, F. HOFFMANN-LA ROCHE LTD, AKACIA HEALTH CARE (PTY)
BOKSBURG, RSA BASEL, SWITZERLAND LTD, ISANDO,
ACORN PHARMACEUTICALS (PTY) AKACIA HEALTH CARE (PTY) LTD, JOHANNESBURG, RSA
LTD, NORTH RIDING, ISANDO, JOHANNESBURG, RSA
JOHANNESBURG, RSA
GOVERNMENT GAZETTE, 6 FEBRUARY 2013
PHARMASPEC CONSULTING
LABORATORIES, FERNDALE,
RANDBURG, RSA
FPRR: MYLAN (PTY) LTD, MODDERFONTEIN, FPRR: ROCHE PRODUCTS (PTY) LTD, FPRR: ROCHE PRODUCTS (PTY) LTD,
JOHANNESBURG, RSA ILLOVO, JOHANNESBURG, RSA ILLOVO, JOHANNESBURG, RSA
AKACIA HEALTH CARE (PTY) LTD, AKACIA HEALTH CARE (PTY) LTD, SEDEK AGRICHEM, DEGRAS ROAD,
ISANDO, JOHANNESBURG, RSA ISANDO, JOHANNESBURG, RSA SILVERTONDALE, PRETORIA, RSA
KHULULEKANI LABORATORY SERVICES
CC, COVENTRY PARK MIDRAND, RSA
FPRR: ROCHE PRODUCTS (PTY) LTD, ILLOVO, FPRR: FPRR:
ROCHE PRODUCTS (PTY) LTD, ILLOVO, MACLEODS PHARMACEUTICALS SA
JOHANNESBURG, RSA JOHANNESBURG, RSA (PTY) LTD, HALFWAY HOUSE, MIDRAND,
RSA